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Transcriptional mechanisms that produce BK channel-dependent
drug tolerance and dependence
Xiaolei Li, Ph.D.
The University of Texas at Austin, 2011
Supervisor: Nigel S. Atkinson
Tolerance to anesthetic drugs is mediated partially by homeostatic mechanisms
that attempt to restore normal neural excitability. The BK-type Ca2+-activated K+ channel,
encoded by the slo gene, plays an important role in this neural adaptation. In Drosophila,
a single sedative dose of the organic solvent anesthetic benzyl alcohol induces dynamic
spatiotemporal changes in histone H4 acetylation across the slo regulatory region and
leads to slo induction and tolerance. Mutations ablating the expression of slo also block
the acquisition of tolerance, whereas activating the expression of a slo transgene results in
resistance to drug sedation. Moreover, artificially inducing histone acetylation with the
histone deacetylase inhibitor causes similar acetylation changes, slo induction, and
functional tolerance to the drug. Histone acetylation changes occur over two highly
conserved non-coding DNA elements, 6b and 55b, of the slo control region. To
investigate the function of these two elements, I generated individual knockout mutants
by gene targeting. Both knockout alleles are backcrossed into the CS wild type
background. The 6b element seems to repress slo induction after drug sedation, because
the 6b knockout allele overreacts to the drug. Compared to the wild type, 6b knockout
allele shows a much greater slo message induction after drug sedation, it also displays
vi
stronger enhancements in seizure susceptibility and following frequency. In addition, the
6b deletion causes a persistent tolerance for at least a month, while tolerance only lasts
about 10 days in wild type flies. My investigation also indicates that the 55b element
limits basal slo expression in muscle. Finally, to investigate if the particular histone
acetylation spikes are required for drug-induced slo induction and tolerance, I tether the
histone-modifying enzymes, HDAC or HAT, to the 6b and 55b DNA elements,
respectively. I observe that the positioning of an HDAC on these two elements blocks
drug-induced slo induction and the development of tolerance. Therefore, histone
acetylation across slo control region is required for the activation of slo and the
acquisition of tolerance.
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Chapter 1: General Introduction
Anesthetic tolerance involves homeostatic regulation of neuronal activity
We use Drosophila melanogaster as a model system to study the molecular
mechanisms behind tolerance to anesthetic drug-induced sedation. Exposure to a sedating
dose of anesthetic drugs, such as ethanol or benzyl alcohol, induces adaptations of the
nervous system that modify the behavioral responses to subsequent drug exposures.
These adaptations cause the duration of sedation to be significantly reduced, and tolerant
animals recover more rapidly from sedation compared to naive animals. This behavior is
called rapid tolerance to drug-induced sedation.
Drug tolerance
Drug tolerance refers to the reduction in the effect of a drug caused by prior
exposure to the drug1. In humans, the acquisition of tolerance to the recreational effects
encourages increased drug consumption in order to achieve the same effect that was
previously experienced. Thus, tolerance promotes drug abuse and addiction, resulting in
serious health and social problems. Anesthetic drugs cause changes in neural excitability,
and the animal responds to these changes by adjusting its physiological processes to
maintain its internal equilibrium in neural activity. Such homeostatic responses oppose
drug effects and are thought to be responsible for drug tolerance, but the same
homeostatic mechanisms persist during drug abstinence and lead to a dependence
symptoms that is also used for the diagnosis of pharmacological drug dependence2.
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Tolerance is considered to be a key endophenotype of addiction3, and genetic pathways
responsible for tolerance may also underlie the changes leading to addiction. Drug
addiction refers to the compulsive consumption of drugs with a loss of control in limiting
intake, and it results in enormous problems in multiple areas, including health care,
quality of life, economy, worker productivity, education and social security, etc.
Compulsive consumption of drugs that leads to addiction is often motivated by severe
social and psychological distress in humans4, however, the great challenge in obtaining a
comprehensive animal model that finely mimic human drug-taking behavior becomes an
unavoidable barrier in addiction study. Therefore, research on the mechanisms behind
tolerance holds the promise of enriching our understanding of drug addiction and could
one day lead to an effective therapy.
Based on the timing of acquisition, tolerance can be grouped into three types.
Acute tolerance appears during a single drug exposure. In contrast, rapid tolerance is
acquired after a single drug exposure. This type of tolerance is usually assayed 24 h after
the initial drug exposure. Chronic tolerance occurs in response to multiple or prolonged
exposure to a drug.
Tolerance can also be mechanistically divided into metabolic and functional
tolerance. Metabolic or pharmacokinetic tolerance is generated by an increase in the rate
of drug clearance. In mammals, metabolic tolerance is often associated with the induction
of liver enzymes that act to clear the drug5. On the other hand, functional or
pharmacodynamic tolerance arises from homeostatic alterations at the cellular targets of
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the drug that compensate for a drug-induced effect.
Our lab uses the following two drugs, the commonly abused drug ethanol and the
volatile anesthetic benzyl alcohol, to study the mechanisms of rapid functional tolerance
in Drosophila. Ethanol is one of the most prevalent and also one of the most well
characterized substances in understanding the mechanisms of addiction. Although a
moderate amount of alcohol is normally harmless, excessive alcohol consumption causes
serious health and social problems. In 2005, alcohol caused 90,000 deaths from road
traffic injuries, cancer, liver disease, alcohol use disorders, hemorrhagic stroke,
arrhythmia and hypertensive disease in the United States6. According to a NIAAA report,
alcohol related problems cost the US economy $185 billion every year7.
Benzyl alcohol (C6H5CH2OH) is a colorless organic compound with a mild
pleasant aromatic odor. Due to its polarity, low vapor pressure and low toxicity, benzyl
alcohol is widely applied in industry as a general solvent for paints, inks, lacquer and
glues. In health care, this compound has also been used as a local anesthetic8-10 and a
bacteriostatic preservative in intravenous medications11. Exposure to high doses of benzyl
alcohol causes toxic effects including respiratory failure, vasodilation, hypotension,
convulsions, and paralysis in humans12. As the primary breakdown product of toluene,
one of the most popular abused inhalant, benzyl alcohol elicits similar phenotypic
responses as ethanol exposure in Drosophila13. Low doses of benzyl alcohol increase
locomotor activity, whereas a higher dose of benzyl alcohol causes hyper-activity,
followed by sedation within 10 minutes. Benzyl alcohol is well-tolerated by flies and can
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be easily administered. It has been shown that flies develop tolerance to benzyl alcohol
sedation after a single drug exposure13. Rapid tolerance manifests itself as a reduction in
the duration of sedation during the second drug exposure. In this study, I use benzyl
alcohol as a representative anesthetic solvent to study the neuronal basis of tolerance to
drug-induced sedation.
The functional diversity of BK channels
The BK type voltage- and Ca2+- activated K+ channels (BK or MaxiK channels)
have a large unitary conductance of 100-300 pS14. BK channels are prominently
distributed to the axons and presynaptic terminals and usually co-located with voltage-
gated Ca2+ channels, and they are also found in cell body and mitochondria15,16. The
channels are activated by both membrane depolarization and increasing intracellular Ca2+
concentration. The opening of channels hyperpolarizes the membrane and inhibits
voltage-gated ion channels, including Ca2+ channels, thus reducing Ca2+ influx.
The BK channel has a complex structure composed of four pore-forming α
subunits, each of which contains seven transmembrane segments (S0-S6) and a big
intracellular COOH-terminus that contains two regulators of K+ conductance (RCK)
domains17. Segments S1-S4 form the voltage sensor, while S5, S6 and their linker amino
acids constitute the pore and selectivity filter. The tandem RCK domains of all the
tetrameric subunits form a intracellular gating ring which contains four Ca2+ binding sites
in RCK2 known as the Ca2+ bowl18.
Functionally, BK channels play important roles in shaping action potential and
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regulating neuronal excitability19. BK channels also affect smooth muscle tone20,21,
neurotransmitter release22, endocrine secretion and electrical tuning in the inner hair
cells23. Recently, BK channels have been shown to play a pivotal role in the regulation of
responses of animals to anesthetic drugs13,24.
It has been shown that the variety of alternative promoter activation and
alternative splicing of BK channels contributes to their structural and functional diversity
in different tissues or cell types. BK channels are encoded by the slo (a.k.a slowpoke)
gene that was originally identified in fruit flies25,26. In Drosophila, the slo gene has a
complex 7 kb transcription regulatory region including five tissue-specific promoters that
control BK channel expression in neurons, muscles, embryonic and larval midgut and
epithelial-derived tracheal cells27-30. In addition, slo has at least 14 alternative exons
distributed among five alternative splicing sites31. Splicing variants of slo differ in
essential features, such as unit conductance, calcium sensitivity and gating kinetics32.
The functional diversity of BK channels is further modulated by β subunits,
regulation by phosphorylation and alternative splicing. In mammals auxiliary β subunits
(β1-4 or KCNMB1-4) regulate BK channel function in various tissues. β1 is the
predominant regulatory subunit in smooth muscle specific expression33 and the β2 subunit
is enriched in kidney and pancreas, whereas β3 and β4 subunits are strongly expressed in
the testes and brain, respectively34,35. In Drosophila, the Slowpoke channel binding
protein (Slob) interacts with the carboxy-termianl domain of the BK channel, and has
been shown to adjust BK channel activity and modulate synaptic transmission36,37.
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In addition BK channels are subject to regulation by phosphorylation by protein
kinases, including protein kinase A (PKA), protein kinase C (PKC), protein kinase G
(PKG), Ca2+/calmodulin-activated protein kinase II (CAMKII) and Src tyrosine
kinase38-41. Coupling of protein kinases and phosphatases to BK channel complexes
allows for modulation of BK channels in vivo.
BK channels are required for the development of tolerance
BK channels are important anesthetic targets as well as pivotal modulators of
behavioral responses to anesthetics. Acute ethanol exposure has been shown to potentiate
BK channels in both mammals and C. elegans42,43. This potentiation is confined to
specific cellular compartments and has been observed in neuronal terminals44. In contrast,
low dose chronic ethanol exposure decreases ethanol potentiation of BK channels and
channel density in a rat neuronal explant model system45.
BK channels have been shown to be involved in the development of tolerance in
mammals24,45. Recently the induction of neural transcription of the slo gene has been
linked to the acquisition of tolerance to the anesthetic benzyl alcohol and to ethanol in
flies. A single exposure to a sedative dose of the drug induces slo transcription, and the
animals display tolerance to the subsequent drug exposure. A mutant that eliminates slo
expression in the nervous system completely blocks the acquisition of functional
tolerance to benzyl alcohol and ethanol, while transgenic induction of a neural isoform of
slo phenocopies tolerance13,46,47.
Generally speaking, the activation of a K+ channel is assumed to hyperpolarize
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neurons and repress excitability. However, the activity of BK channels has been
positively correlated with neural excitability by reducing the refractory period while
enhancing the firing rate of neurons48-52. The refractory period is the time it takes for the
neuron to be ready to fire again. Using electrophysiological methods we have shown that
benzyl-alcohol-induced BK expression enhances the following frequency of neurons,
thereby increasing seizure susceptibility and neural excitability. This enables the animal
to resist subsequent drug sedation53.
Drug-induced epigenetic modifications regulate BK channel expression
In the nucleus of eukaryotic cells, DNA exists as a highly condensed structure
known as chromatin that consists of DNA and packing proteins known as histones.
Environmental factors cause changes of the chromatin structure that provide unique
control over gene expression through gating access of transcription factors to DNA. By
definition epigenetics is "the mechanism for the stable maintenance of gene expression
that involves physically 'marking' DNA or its associated proteins"54. In other words,
epigenetics refers to the structural adaptation of chromosomal regions that alters gene
activity55. Epigenetic mechanisms are important for normal development and cell
differentiation.
The basic unit of chromatin is the nucleosome that consists of a segment of 146 bp
of DNA wound around a histone core. Histones are assembled as an octamer of two
copies of H2A, H2B, H3 and H4. The structure of chromatin is highly condensed and is
regulated by the methylation of DNA at CpG residues and by covalent post-translational
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modifications of the amino or carboxy termini of histones that include acetylation,
methylation, phosphorylation, ubiquitylation and sumoylation56. These modifications
cause changes in the chromatin structure and the accessibility of transcription factors and
RNA polymerase, thus influencing gene expression.
Most of the histone modifications identified to date are dynamic and potentially
reversible, and are modified by specific enzymes that add or remove the modifications
from their substrates. For example, histone acetyltransferases (HATs) add acetyl groups
to lysine residues of histones, while histone deacetylases (HDACs) remove them. Histone
methyltransferases (HMTs) and demethylases (HDMs) regulate the addition and removal
of methyl groups.
Histone modifications play an important role in the regulation of transcription,
DNA repair, replication and chromosomal condensation56. As the most well studied
histone modification, histone acetylation occurs in both the nucleus and cytoplasm. The
amino termini of histones are more accessible for modification by acetylation, and the
well studied acetylation sites include K9, K14 and K18 of histone H3, and K5, K8, K12
and K16 of histone H4. Histone acetylation affects gene expression through two main
mechanisms. First, acetylation of lysine residues decreases their positive charge and thus
their electrostatic interaction to the negatively charged DNA. It has been shown that the
amino terminal tail of H4 (residues 16-25) of one nucleosome interacts with an acidic
pocket in a H2A-H2B dimer of the adjacent nucleosome. And neutralizing the positive
charges of the H4 amino terminal tail by acetylation would break the interaction and
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prevent the cross-linking between adjacent nucleosomes57. The physical relaxation of
chromatin structure caused by histone acetylation stimulates gene transcription by
increasing accessibility to the transcription apparatus. Second, acetylated histones are
also attractive to transcription factors that contain the bromodomain, a ~110-amino-acid
motif found in many chromatin-associated proteins58. For example, TAFII250 has two
bromodomains that are capable of recognizing two neighboring acetylated lysines in
partially acetylated inactive chromatin. TAFII250 together with its partners, the TATA-
binding protein (TBP) and other TAFIIs, recruits other components of the transcriptional
machinery to activate gene transcription59. Genome-wide acetylation analyses have
shown that hyperacetylation in promoter regions are strongly correlated with gene
activation, whereas hypoacetylation is correlated with gene repression60,61. Histone
methylation marks are involved in the activation or repression of gene transcription, and
transcriptional elongation62,63. For example, methylation of H3K4 is associated with gene
activation, whereas H3K9 and H3K27 are associated with repression64. Histone
phosphorylation is usually associated with activation of gene transcription65.
Chromatin modifications have been shown to be involved in drug-related
behaviors, such as addiction. Cocaine induces various histone modifications, including
acetylation, phosphorylation and methylation, at specific gene promoters in the nucleus
accumbens66. Inhibition of HDACs in vivo up-regulates histone acetylation and
potentiates the rewarding effects of cocaine66. Moreover, CBP (a HAT) deficient mice
show reduced histone acetylation and decreased sensitivity to cocaine67. The above
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evidence suggests that gene specific histone acetylation affects behavioral sensitivity to
cocaine.
In Drosophila, the activation of slo transcription contributes to the development of
tolerance13. Moreover, a single sedative exposure of benzyl alcohol causes a dynamic
histone H4 acetylation pattern within the transcriptional control region of the slo gene.
The hyperacetylation changes are detected at neuronal promoters C0 and C1, as well as
the evolutionarily conserved DNA elements 6b and 55b. Repression of HDACs with a
universal inhibitor (sodium butyrate) causes hyperacetylation at the 6b element, induces
slo transcription and phenocopies tolerance. Furthermore, the CREB transcription factor
is required for all of these drug-induced changes. Activation of a CREB dominant-
negative transgene blocks histone acetylation at slo promoter regions, induction of slo
message and tolerance68,69.
Drosophila melanogaster is a good model organism for the study of tolerance
The fruit fly, Drosophila melanogaster, has been extensively used as a model
organism for over 100 years since Morgan first worked on them to define the rules of
genetics. Drosophila have many advantages as a model system. They are easy to culture
and inexpensive to house. The life cycle is short (about two weeks), making it possible to
study multiple generations in a few months.
In spite of the simplicity in genetics and anatomy, flies parallel many aspects of
biology observed in so called "higher" organisms such as humans. As a well-studied
model organism with a long established history, flies have powerful genetic and
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molecular tools. The Drosophila genome has been completely sequenced and is well
annotated, and mutants in most genes are available in the stock centers70. Drosophila and
humans show conservation in synaptic vesicle release and recycling, signal transduction
and neurotransmission71,72. Moreover, Drosophila and human genetics share similarities
despite the difference in the genome sizes and quantity of genes. More than half of all
Drosophila protein sequences share similarity with those of mammals, and sixty percent
of human disease genes have counterparts or homologues in Drosophila73. Thus
Drosophila has been increasingly used as disease models in drug studies because of its
advantages in genetics74.
Behaviorally fruit flies are capable of exhibiting many complex behaviors as do
humans, e.g. circadian rhythm, drug responses, sleep, locomotion, courtship, fighting,
aggressive behavior, learning and memory, cooperation and goal-driven behavior75-78.
Drosophila and mammals also have conserved responses to anesthetics. For example, low
doses of ethanol are excitatory and high doses cause incoordination, unresponsiveness
and sedation. The volatile anesthetic benzyl alcohol and the abused drug ethanol cause
similar responses in Drosophila13,46.
Dissertation overview
The overall goal of my work is to enrich the understanding of transcriptional
regulation mechanisms involved in the development of rapid functional tolerance to the
anesthetic benzyl alcohol in the Drosophila melanogaster model system. More
specifically the investigation aims to explore the roles of the evolutionarily conserved
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DNA elements 6b and 55b present in the promoter of the slo gene and their roles in the
induction of slo expression in response to benzyl alcohol sedation and on the production
of tolerance.
Chapter 2 focuses on the characterization of the 6b enhancer. This chapter first
shows the generation of a 6b knock-out mutant slo∆6b, followed by the time-course
analysis of slo∆6b mutant with respect to behavioral tolerance, tissue-specific slo
expression and histone H4 acetylation. It also covers investigation of other behaviors that
have been associated with slo, such as seizure susceptibility and circadian rhythmicity.
Chapter 3 is the analysis of 55b enhancer. This chapter describes the generation of
a 55b knock-out mutant slo∆55b and the molecular and behavioral analyses of the mutant.
The molecular analysis includes the study of the basal and drug-induced slo expression in
different tissue and drug-induced histone H4 acetylation changes. This chapter also
includes an extensive behavioral study of the mutant.
Chapter 4 shows the results of the analysis of the impact of endogenous histone
acetylation levels on slo transcription and functional tolerance. It starts with the details of
the construction of a two-part system in which a histone acetylation modifying protein
such as an HDAC or a HAT is tethered to the 6b and 55b elements, respectively. The
chapter also shows the effects of this approach on drug sensitivity, functional tolerance
and slo expression under the influence of either an HDAC or a HAT.
An extensive discussion of the results and detailed descriptions of the methods are
12
included in the corresponding sections of Chapters 2-4. Finally, Chapter 5 presents a
summary of the results of the study and suggestions about further directions.
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Chapter 2: The 6b element regulates drug tolerance and withdrawal
Introduction
Functional tolerance is a reduction in the response to a drug caused by prior drug
exposure. Drug tolerance and withdrawal have long been thought to have a common
origin in the homeostatic changes that counter the effects of a drug. These changes which
produce tolerance to subsequent drug exposure persist after drug clearance to generate
withdrawal symptoms–a sign of physiological dependence79,80. In Drosophila, sedation
with an organic solvent induces functional behavioral tolerance and a dependence
phenotype (reduced seizure threshold) that have been shown to be caused by induction of
the slo BK-type Ca2+-activated K+ channel gene53. In response to a single sedation with
the organic solvent anesthetic, benzyl alcohol, the excitability of the fly nervous system is
altered, making the animal resistant to a subsequent benzyl alcohol sedation delivered on
the following day. During the second benzyl alcohol exposure, the increased slo
expression acts as a neural excitant that counters drug sedation. However, after drug
clearance, the slo-induced increase in neural excitability persists, enhancing the
susceptibility for seizures. Mutations that ablate neural slo expression block the
acquisition of both the tolerance and withdrawal endophenotypes, while activating a slo
transgene in the nervous system phenocopies tolerance when the flies are exposed to the
drug but induces the withdrawal endophenotype in the absence of the drug13,53.
The role of slo in response to organic solvents is highly conserved through
14
evolution. A single slo BK channel gene exists in Drosophila, Caenorhabditis, and
mammals. BK channel activity has been shown to be modulated by organic solvents in
both C. elegans and mammals and the behavioral response of C. elegans to ethanol
sedation has been genetically linked to the gene81-83. The slo gene also contributes to the
generation of similar neural responses in mammals. MicroRNA-regulated expression of
slo BK channels have been shown to underlie physiological ethanol tolerance in the rat
hypothalamo-neurohypophysial explant system84. The strong evolutionary concordance
between invertebrates and vertebrates with regards to these responses means that
invertebrate genetic model systems can be used to identify the general principles of how
nervous systems homeostatically modulate their activity to become tolerant to organic
solvent intoxication. Because tolerance and dependence have related origins, a
description of the cellular mechanics underlying the production of tolerance is likely to
help us understand cellular changes that lead to physiological dependence. Adult
Drosophila are ideal for the study of functional tolerance because they do not develop
metabolic tolerance to organic solvents (increased rate of clearance)85.
The Drosophila slo gene has a complex 7 kb control region, containing at least
five core promoters (transcription-start sites) that mediate developmental- and tissue-
specific expression. Benzyl alcohol sedation activates the neural-specific core promoters
(so-called Promoters C0 and C1, Fig 2.1) to induce slo expression in the nervous system.
The identification of control elements that mediate this induction might be difficult
because DNA regulatory elements are often small and function only in their native
context86. To circumvent this obstacle, we used benzyl alcohol-induced changes in
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histone acetylation to map the position of DNA elements that have a functional role in
benzyl alcohol producing tolerance. The rationale for this approach is that histone
acetylation is a common early step in the activation of transcription. Transcription factors
acetylate histones to enhance the accessibility of the underlying DNA for protein binding
and acetylated histones are also binding sites for bromodomain-containing transcription
factors that stimulate transcription58. A survey of changes in histone modification can
provide a record of recent transcription factor activity and is a reliable way to identify
enhancers that regulate gene expression87. We have used the spatiotemporal pattern of
histone H4 acetylation across the slo promoter region to identify a DNA element that is
functionally important for the induction of the slo gene to benzyl alcohol and the
resulting manifestation of benzyl alcohol tolerance and dependence. We focused our
attention on DNA sequences underlying a discrete benzyl alcohol-induced histone
acetylation spike across the 6b element. This highly conserved ~60mer situated between
the two neural promoters was shown to underlie a strong and focused drug-induced
histone H4 acetylation peak that coincided with induction of the neural promoters68 (Fig
2.1). Furthermore, feeding flies the HDAC inhibitor, sodium butyrate, specifically
enhanced 6b acetylation, induced slo neural expression and phenocopied functional
benzyl alcohol tolerance in a slo-dependent manner. Here we show that element 6b plays
a specific role in limiting the response of the slo gene. Removal of the 6b element, by
homologous end-outs gene targeting88, produces a slo allele hypermorphic with respect to
drug sedation; increasing gene induction to produce functional tolerance that lasts for an




Removal of the 6b element from the slo promoter region.
In order to investigate the function of the 6b element in the regulation of the slo
gene and in the development of tolerance to drug-induced sedation, mutations that
abolish the element were generated through homologous recombination-based ends-out
gene targeting (Fig. 2.2). Correct targeting events were verified by Southern blotting
analysis (Fig. 2.3), genetic linkage and DNA sequencing. The derived slow∆6b strain was
unable to acquire tolerance to benzyl alcohol (data not shown). However it still carries a
4.5-kb white+ gene between the neural promoters C0 and C1 and this may disrupt slo
transcription by interfering the alternative promoter activation or RNA splicing.
Therefore the white+ marker gene was removed by cre-lox recombination to obtain the
slo∆6b allele that was subsequently backcrossed to the wild type Canton S background for
six generations to minimize genetic difference between the mutant and wild type lines.
The slo∆6b homozygotes are healthy with no obvious physical abnomalities or deficiencies
in growth rate or development (data not shown). Because loxP sequences have not been
reported to be transcriptionally active and because two other loxP insertions into the slo
transcriptional control region had none of the consequences attributed to the slo∆6b allele
(data not shown), we ascribe the changes described below to the removal of element 6b.
All of the original seven slo mutant alleles are believed to be null mutations, either
failing to express protein or producing a protein that fails to assemble into a functional
channel25. These mutant alleles manifest extremely similar changes in behavior. Without
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any sort of pretreatment, null mutations in slo moderately impair rather simple behaviors,
reducing the rate of walking, the ability to climb, and the capacity for flight. All also
display the so-called "sticky-feet" phenotype in which a short stimulation with heat,
followed by a return to ambient temperature causes the flies to behave as if their feet are
stuck to the surface upon which they stand. In addition, slo null mutants have been shown
to almost completely lack circadian rhythms and to be unable to acquire behavioral
tolerance to sedation by benzyl alcohol13,25,89. With regard to all of these behaviors, slo∆6b
mutants are behaviorally indistinguishable from wild type animals (Fig. 2.4, 2.12A, B,
D).
A single drug sedation induces abnormal long-term tolerance in slo∆6b.
At first, the mutant was assayed for resistance to anesthetic benzyl alcohol. Age-
matched female flies of CS and slo∆6b were sedated by a single benzyl alcohol exposure. I
found that both slo∆6b and CS flies recovered at the same rate (Fig. 2.5), suggesting this
mutation did not affect intrinsic sensitivity for sedation with benzyl alcohol. Next, the
mutant was subjected to a tolerance time-course assay to investigate if the 6b element is
related to the acquisition or the duration of tolerance. The interval between the first drug
sedation and the tolerance assay was 1 d, 4 d, 7 d, 14 d, 21 d and 28 d, respectively. As
shown in Fig. 2.6, tolerance in CS strain persisted for about 1 week, whereas the slo∆6b
still showed strong tolerance even 28 days after the first drug exposure. I did not further
extend the tolerance time-course beyond 28 days because after a month, the flies were
weak and a large fraction of them could not survive the drug sedation. The prolonged
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tolerance is a unique phenotype that has only been detected in slo∆6b mutants. The same
prolonged tolerance is also observed for ethanol-induced sedation in the 6b mutant (data
not shown).
The slo∆6b mutants shows an amplified transcriptional response to drug
sedation.
Induction of neural slo transcription and tolerance are closely connected. I used
RT-PCR to quantify the relative abundance of mRNA expressed from the neural
promoters before and after benzyl alcohol sedation. In animals that had never been
sedated, the mutant displayed the same relative abundance of neural slo mRNA as did the
wild type (CS) fly (Fig. 2.7A), suggesting the deletion of the 6b element did not affect
basal slo transcription. However benzyl alcohol sedation caused a 150% transient neural
slo message induction in slo∆6b, whereas the induction in CS was only 50-60% (Fig. 2.7B,
C). The transcription of slo returned to normal in both strains 24 h after sedation (Fig.
2.7D, E).
Prolonged tolerance might be caused by a pulsatile reactivation of the gene that
maintains an elevated level of BK channel activity. In mammals a single kainate injection
has been shown to cause a chronic behavioral change that involves multiple gene
inductions, including a short acute induction and a delayed induction persisted for several
weeks90. To explore if the chronic tolerance in slo∆6b also derives from subsequent slo
transcriptional inductions, I carried out a time-course analysis that monitored slo mRNA
abundance in the nervous system from 6 h to 28 d after a single benzyl alcohol sedation
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(6 h, 1 d, 4 d, 7 d, 14 d, 21 d and 28 d). However, the time-course analysis did not show
evidence of an additional round of slo induction. It appears that the abnormal longevity of
tolerance is the product of single burst of slo expression. (Fig. 2.8).
Quantification of histone H4 acetylation across the slo control region.
Histone acetylation at H4 has been connected to slo induction and the
development of tolerance. The drug induced histone acetylation pattern in slo∆6b was
investigated by chromatin immunoprecipitation (ChromIP) assay with anti-H4Ac
antibody, and real-time PCR was performed to quantitate the amount of DNA
precipitated in the assay. The regions assayed for histone acetylation includes tissue
specific promoters (neural promoters C0 and C1, midgut promoters C1b and C1c, and
muscle promoter C2), two putative CRE sites and evolutionarily conserved DNA
elements 4b, 6b and 55b (Fig. 2.9A). The Glycerol-3-phosphate dehydrogenase (Gpdh)
gene was chosen as the internal control because its transcription and acetylation levels are
independent of benzyl alcohol sedation68.
Histone acetylation was finely focused at neural promoter C0 6 h after sedation
(Fig. 2.9B), meanwhile neural slo transcription was remarkably induced. However, at this
time point drug sedation also caused acetylation spikes across 6b and C1 in CS wild type
flies. Therefore the 6b deletion also blocked the hyperacetylation across C1. By 24 h,
acetylation level returned to the baseline level and the peak over C0 disappeared (Fig.
2.9C), meanwhile the slo transcription returned to normal levels. A no-antibody control
was included in each ChromIP assay to confirm the specificity of the antibodies and to
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validate the assay. It shows the amount of DNA non-specifically bound to protein G
beads (noise). In the assay it is poorly amplified in the real time PCR compared with co-
immunoprecipitated samples (signal), indicating that the abundance of DNA in the no-
antibody control is either undetectable or negligible.
Sedation caused a greater enhancement in seizure susceptibility in slo∆6b.
Previously, slo induction caused by prior benzyl alcohol sedation and the
overexpression of slo have been shown to reduce the seizure threshold of flies53. The
seizure susceptibility assay was performed to investigate the effect of the slo∆6b mutation
on this response. Seizures are symptoms caused by transient, abnormally excessive
electrical activity in the brain. Clinically, seizures have been related to alcohol acute
intoxication and withdrawal91. In Drosophila, drug-induced slo expression is both
necessary and sufficient for the enhancement of seizure susceptibility53. In the study, the
seizure phenotype was triggered by a train of high-frequency electroconvulsive shock at
escalating voltages and the seizure phenotype was identified as a high-frequency
spontaneous initial discharge followed by a failure period to response and a delayed
secondary discharge (Fig. 2.10A). Seizure susceptibility was represented by seizure
threshold, which was determined as the lowest voltage that induces the behavior
successfully.
The average seizure stimulus voltages in CS and slo∆6b was measured before and
after BA sedation. In CS flies, the seizure threshold was 34.4 ± 6.3 V before sedation,
and 24.4 ± 2.4 V after sedation. Before sedation, the slo∆6b flies exhibited an average
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seizure threshold of 26.1 ± 4.1 V, while the stimulating voltage dropped to 12.8 ± 1.2 V
one day after benzyl alcohol sedation (Fig. 2.10B). The slo∆6b mutant exhibited a
significant lower seizure threshold compared with wild type flies before and after benzyl
alcohol sedation.
To more clearly illustrate the effect of the mutation on benzyl alcohol-induced
change in seizure threshold, the percentage change in seizure threshold was calculated by
normalizing the reduction in the seizure threshold voltage by the control voltage. Benzyl
alcohol induced a bigger percentage change in the seizure threshold voltage in slo∆6b flies
than in the wild type. The CS flies showed a reduction of 29.0 ± 3.2 percent in seizure
voltage, whereas the percentage was 51.0 ± 4.2 in slo∆6b (Fig. 2.10C). I also tracked the
seizure susceptibility at 7 d and 14 d post benzyl alcohol sedation. No seizure
susceptibility difference was detected between the sedated and control flies, or between
the wild type and mutant flies (Fig. 2.10D, E).
slo∆6b exhibited a larger increase in the neuronal following frequency after drug
exposure.
The following frequency profile of the giant fiber pathway was explored to
demonstrate the effect of the 6b element deletion on neural excitability. Flies were given
trains of stimuli with a frequency ranging 40 to 220 Hz. As the frequency increases, the
interval between two adjacent stimuli reduces. Animals fail to respond to the stimuli
when the interval reaches the refractory time. Therefore the magnitude of following
frequency shows how fast the neuron can fire. The following frequency with 50%
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response rate (FF50) was determined and data were plotted in Fig. 2.11. The average
FF50 was increased in both mutant and wild type by 24 h after benzyl alcohol sedation.
The induction was approximately 24.4% in CS and 46.8% in the mutant. Again, the slo∆6b
mutant displayed a two-fold change in response compared to wild type. 
The slo∆6b mutants were more rhythmic than wild type animals.
Circadian patterns of activity and sleep of CS, slo∆6b, and slo4 flies were compared
using recently eclosed flies that were entrained in LD for 3 days before being transferred
to DD and monitored for 6 days. The CS wild type showed rhythmic oscillations in both
activity and sleep while the slo4 loss-of-function mutants were behaviorally arrhythmic
(Fig. 2.12A) with regard to both parameters. The overall activity levels of slo4 animals
were much higher than the wild type. With regard to these measures the slo∆6b mutant
closely resembled wild type in terms of general level of activity and the periodicity of
circadian oscillations (Fig 2.12B, D). Intriguingly, the slo∆6b strain had a higher index of
rhythmicity than even the wild type (Fig. 2.12C).
The slo gene has been shown to be under circadian regulation, and its expression
is found to cycle along with a slo binding protein89. It is possible that the increase in the
behavioral rhythmicity index, described above, is caused by more robust cycling of slo
gene expression. To find out if the 6b deletion mutation causes the expression of slo to be
more regular, I performed a time-course analysis of the circadian pattern of neural slo
expression for two days under free-running conditions. I assayed neural slo mRNA
abundance, with RT-PCR, at time points associated with the peak and valleys of slo
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expression as described in the literature89. As shown in Fig. 2.13, both wild type and the
mutant exhibited a rather "flat" expressing pattern. No significant difference was detected
between the two circadian patterns of expression.
Discussion
This work represents a novel discovery, a cis-acting DNA regulatory element that
specifically modulates a complex behavioral response to a drug. The slo gene encodes the
BK type calcium-activated potassium channel that is expressed in all or most neurons in
the central nervous system28. In accordance with this broad expression pattern, loss-of-
function mutations in slo are behaviorally pleiotropic. These animals are uncoordinated,
fly poorly, lack circadian rhythms, exhibit sticky feet paralysis in response to
overstimulation, are slightly resistant to seizures and fail to acquire rapid tolerance to
sedation with organic solvents such as benzyl alcohol13,89,92. The 6b element, which is
positioned between the two neural core promoters of the slo gene, appears to be
specifically involved in the homeostatic regulation of neural expression. While we cannot
easily visualize changes in expression in different structures within the brain, the
determination by RT-qPCR that slo∆6b homozygotes have the same relative abundance of
slo neural-specific transcripts and the fact that the mutant animal lacks non-drug related
slo phenotypes is consistent with the interpretation that the effect of the mutation on basal
expression from the gene is minimal. The slo∆6b mutation disrupts only the drug-related
phenotypes–seizure threshold and functional tolerance but does not generate any of the
other phenotypes caused by loss-of-function mutation in slo.
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Wild type animals respond to benzyl alcohol sedation with a 24 h increase in the
slo expression that has been directly linked to the production of functional tolerance to
sedation13. Functional tolerance, however, outlasts the period of slo induction by about 9
days. The slo∆6b mutant over-reacts to drug sedation producing a greater induction of slo
expression although the duration of induction appears to be unchanged. This overreaction
at the molecular level appears to precipitate a rather substantial increase in the behavioral
response. The mutation vastly exaggerates the duration of functional tolerance from ~10
days to at least 28 days. Technical limitations prevent us from assaying tolerance after
this point therefore, twenty-eight days is the lower limit on the duration of tolerance in
the mutant.
While transient drug-induced induction of slo must produce channels that outlive
the window of increased gene expression, it seems improbable that in 24 h the mutant
allele could produce a sufficient superabundance of BK channels to maintain tolerance
for at least 28 days. We cannot directly measure the abundance of the BK channel protein
because antibodies specific for the Drosophila protein no longer exist and the gene has
not yet been epitope tagged. However, the time-course of another slo dependent behavior
suggests that the increase in channels is short lived.
Previously, it has been shown that the seizure threshold of flies is inversely
related to the neural expression of the slo BK channel gene53. Electroconvulsive
stimulation of fly brain, through electrodes placed on the eyes, generates a seizure. This
patterned seizure is characterized by an initial electrical seizure, a refractory period
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during which the animal is unresponsive to stimulation, and a secondary spontaneous
seizure after which the nervous system once again becomes responsive to stimulation.
Null mutations in slo make the animals seizure resistant while increased gene expression
results in seizure sensitization (reduction in the seizure threshold)53. The increase in BK
channel activity reduces the seizure threshold by shortening the neuronal refractory
period. By definition, this response is a withdrawal phenotype since it is precipitated by
drug exposure but is apparent after drug clearance. Here we show that there is a clear lack
of correspondence between the duration of the reduction in seizure threshold and the
duration of functional tolerance. This strongly suggests that a global increase in BK
channel density does not persist for the entire 28 d period.
The difference in the time-course of tolerance and the seizure response suggests
that tolerance must be produced by a structure in the brain that does not contribute to the
seizure phenotype and that in this structure that the dysregulation of slo∆6b allele extends
to the duration of expression. In this proposed neural structure, the slo∆6b allele must
become persistently active following benzyl alcohol sedation.
The 6b element was identified as a candidate element because it underlaid a drug-
induced histone acetylation spike. In wild type, increased histone acetylation persisted
over 6b for 24 h after benzyl alcohol sedation. Furthermore, the HDAC inhibitor sodium
butyrate induced slo expression, phenocopied tolerance, and generated a single
acetylation spike over element 6b. This led us to hypothesize that a histone deacetylase
was chronically active at 6b and that perhaps the regulation of this deacetylase
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contributed to slo induction. The response of the slo∆6b mutants to benzyl alcohol sedation
suggests that this interpretation is correct. That 6b is a negative regulator of slo
expression.
We used the drug-induced H4 acetylation profile as a convenient indicator of
transcription factor activity. While we do not know which transcription factor, or how
many are acting, we know where and when they act. Acetylation in the vicinity of
transcriptional promoters is usually associated with an increase in promoter activity93.
The histone acetylation profile of the slo∆6b mutant suggests that the 6b element
differentially regulates the neural-specific core promoters C0 and C1. After sedation, the
acetylation over Promoter C0 is augmented while the drug-induced acetylation at C1 is
suppressed. Thus in the wild type, we propose that the 6b element limits the activation of
core promoter C0 and enhances activation of core promoter C1.
BK channels expressed from the slo gene have been shown to underlie a form of
ethanol functional tolerance described in the the rat hypothalamic-neurohypophysial
explant system24. In this system, ethanol potentiates BK channels activity which leads to
an increase in firing and a suppression of hormone release. However, chronic ethanol
exposure leads to tolerance. Tolerance is produced by the internalization of preexisting
channels. Activation of a microRNA (mir9) targeting slo transcripts encoding ethanol
sensitive channels shifts expression to the production of ethanol resistant BK channels in
both the HNS and medium spiny neurons of rats84. In mammalian model systems of slo
dependent ethanol tolerance, transcriptional regulation has not been identified as a key
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factor, nor has post-transcriptional regulation been identified as important in the
Drosophila model of organic solvent tolerance. This may however be a product of the
different properties and experimental advantages offered by each model system although
it is also possible that different organisms emphasize different regulatory regimens.
This study demonstrates the profound utility of epigenetic histone modifications
to map the position of DNA elements that mediate specific regulatory responses. Histone
modifications serve as molecular footprints that visualize the action of transcription
factors. Such a method preselects for regulatory elements that are of functional
importance and narrows the field of elements that must be functionally tested in order to
understand how the genome senses and responds to the environment.
The 6b element, as the key part of our working model for drug-responsive slo
induction, possibly acts as a repressive control element of the slo gene. The chromatin
within slo regulatory sequences has a dynamic structure varying between the active, loose
state and an inactive, tight status. Before drug sedation, an HDAC is probably docked in
close proximity to the 6b element and inhibits histone acetylation, thus the slo regulatory
region is in the inactive state and gene expression repressed. When drug sedation activate
histone acetylation and turn the chromatin into an active state, slo expression is induced.
Examination of the 6b element shows that it contains transcription factor binding
site motifs that might account for this mutant phenotype. Within 6b there is an HSE motif
that could be recognized by the heat shock regulatory transcription factor (HSF). HSF has
been shown to regulate histone acetylation levels in the mammals through its association
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HDAC1 and HDAC294. The drug-induced stress may induce transcription factor HSF,
which might help to position HDACs at 6b to deacetylate histone and compact chromatin,
thus repressing transcription. Deletion of the 6b element might permanently prevent the
positioning of regulatory HDACs that are used to limit or terminate homeostatic
activation of the slo gene and thereby the mutant over-responds to induction by benzyl
alcohol.
Last but not least, slo∆6b demonstrated a more regular rhythmic activity cycle
compare with CS wild type. The Drosophila slo gene has been shown to be under
circadian regulation, as the expression of the gene is found to be cycled along with a slo
binding protein89. In this study, both wild type and the mutant exhibited a rather "flat"
expressing pattern, and no significant difference was detected between them. However,
the results do not necessarily disprove the causation between the slo expression cycle and
the rhythmicity enhancement of activity. It is also possible that the enhancement of cell
specific slo cycling leads to this behavior.
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Figure 2.1. Map of the slo transcriptional control region and areas showing
enhanced histone acetylation after drug sedation. The graph shows the 7-
kb control region of slo includes five tissue-specific promoters. They are
neuronal promoters C0 and C1; midgut promoters C1b and C1c; muscle
and tracheal cell promoter C2. The transcriptional start sites are indicated
by arrows. Boxes below the line identify exons. lines connecting exons
represent their splicing pattern. Black boxes below the line denote the
position of non-coding evolutionary-conserved DNA elements. The table
shows the time-course of histone H4 hyper-acetylation for 48 h after
benzyl alcohol sedation (column H4 Acetylation) for each of the
conserved elements and correlates this with increased accumulation of slo
mRNA in the nervous system (column RNA) and the appearance of
functional tolerance (column Tolerance). The number of plusses and
arrows corresponds to the histone H4 hyperacetylation level and the
relative abundance of slo mRNA, respectively. Checks identify when
behavioral tolerance can be detected. Behavioral tolerance to benzyl
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Figure 2.2. Deletion of the 6b element by ends-out gene targeting. A) The
targeting scheme. The donor construct contains two pieces of inserts
(white boxes) homologous to the flanking sequences of the 6b element
(grey boxes). The homologous recombination between the two inserts and
their chromosomal counterparts resulted in the replacement of the 6b
element by a white+ gene. A Cre recombinase is used to hop out the white+
that has lox sites on both ends. In slo∆6b allele the 6b element is substituted
by a lox site. B) The outline of crossing scheme for 6b targeting. The
donor transgenic DNA on the second chromosome is used to target slo on
the third. Linearized extrachromosomal donor fragment derived from two
transgenes: FLP pops out the donor DNA from the second chromosome as
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Figure 2.3. Southern blotting analysis of targeting events confirm
homologous recombination into the slo locus. Panel A shows the Southern
blot and panel B shows the corresponding restriction map. The source of
the BsoBI-disgested genomic DNA is marked above each lane in panel A.
WT refers to the w1118 recipient line which produces a 8.5 kb band. The
slow∆6b / + heterozygote produces two bands that match the predicted size
of 8.5 and 4.7 kb. The slow∆6b/slow∆6b homozygotes produce only the 4.7 kb
band predicted to be produced by correct targeting of the transgene. slow∆6b
contains a mini-w+ transgene flanked by loxP sites. Removal of mini-w+
by Cre-LoxP recombination generated allele slo∆6b in which 6b has been
replaced by loxP. slo∆6b/slo∆6b homozygotes produce a BsoBI band of 8.5
kb. The DNA fragment used as the probe and he expected fragments from

































Figure 2.4. The slo∆6b fly showed normal locomotor activities. A) slo∆6b
showed normal walking distance in a 10 min free walking test. B) The
slo∆6b flies showed normal climbing ability. Flies that climbed beyond 10
cm within 10 sec were considered as passing the climbing assay. Over
95% of CS and slo∆6b flies passed the climbing test, whereas the percentage
of slo4 stock was only around 30%. C) The 6b deletion did not affect flight
capacity. Flies were dropped into a 15 × 62 cm pipette jar through a funnel
at the top. The falling flies flew toward the wall and were stuck in the
mineral oil pre-coated on the wall. Wild type and slo∆6b animals flew well,
and most of them were found within 10 cm to the top. In contrast slo4
animals flew poorly and were evenly distributed along the wall. Student's
t-test and one-way ANOVA with Dunnett's post hoc test, *P ≤ 0.05; **P ≤
0.01. Error bars represent SEM.
















































Figure 2.5. The deletion of the 6b element did not affect drug resistance.
Recently eclosed female flies were sedated by BA and then transferred to
clean vials to recover. The recovery curves were plotted as the percentage
of flies that have been returned to climbing from sedation. The difference
between recovery curves of wild type fly (black) and slo∆6b (grey) are not
significant. The slo∆6b strain had been backcrossed to CS wild type for six
generations. The statistical significance between the two recovery curves
was determined by log-rank test. Error bars represent SEM (standard error
of the mean).




















































Figure 2.6. Benzyl alcohol caused long-term tolerance in slo∆6b flies. The
recovery curves describes the percentage of flies that have been recovered
from the first sedation (gray) and the second sedation (black). Tolerance
lasts for at least 28 d in slo∆6b, however, it is detected in wild type for only a
week. Log-rank test. *P ≤ 0.05. Error bars represent SEM.
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Figure 2.7. The analysis of slo transcription in slo∆6b flies. The mRNA
levels of slo were determined by real-time RT-PCR using primers that
only amplify neural slo transcripts. A) The 6b ablation did not affect the
basal slo expression (P = 0.859). B) Benzyl alcohol induced neural slo
transcription in WT at 6 h after sedation (**P = 0.0012). C) The
transcription of slo was induced in the mutant 6 h after benzyl alcohol
(BA) sedation (***P = 0.0003). D) The slo transcription in WT returned to
baseline 24h after sedation (P = 0.4689). Unpaired t-test, n = 3. Error bars
represent SEM. E) The transcription of slo returned to normal in slo∆6b 24h





























































































































































Figure 2.8. The time-course analysis of slo transcription in slo∆6b. The
mRNA levels of slo were determined by real-time RT-PCR using C1
primers that only amplify neural slo transcripts. Unpaired t-test, n = 3-6,
**, P≤0.01. Error bars represent SEM.




















Figure 2.9. Patterns of histone H4 acetylation across slo transcriptional
control region in slo∆6b after benzyl alcohol sedation. A) Map of the slo
transcriptional control region and areas assayed in ChromIP. Arrows
identify the position of the tissue-specific slo core promoters and open
boxes on the line represent exons. The black boxes below the line show
the conserved elements tested in the ChromIP assay. In slo∆6b the 6b site
was replaced by a loxP element. B) H4 acetylation levels 6 h after BA
sedation detected in wild type and slo∆6b. The fold change of acetylation
was the ratio of the acetylation levels of drug sedated flies over untreated
ones. C) Acetylation state surveyed 24 h after BA sedation. One-way
ANOVA with Dunnett's comparison post tests, n=3, *P ≤ 0.05, **P ≤
0.01. Error bars represent SEM.
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Figure 2.10. Drug sedation caused a much greater transient enhancement
of seizure susceptibility in slo∆6b. Electroconvulsive stimuli (ES) of varying
voltages ranging 5-50 V were utilized to determine the seizure
susceptibility, which is represent by the minimum stimulus voltage to
trigger seizure. A) The seizure phenotype was identified as a high-
frequency spontaneous initial discharge (ID) followed by a failure period
to response and a delayed discharge (DD). B) The average stimulus
voltages in CS and slo∆6b measured one day after BA sedation. The slo∆6b
mutant exhibited a significant lower average stimulus compared with wild
type flies. BA sedation reduced stimulus voltage in both stocks. C) The
percentage of stimulus voltage reduction in CS and slo∆6b. D) The average
seizure stimulus voltages of CS and slo∆6b 7 d after sedation. E) The
average seizure stimulus voltages 14 d after sedation. Student's t-test, *P ≤
0.05; **P ≤ 0.01. Error bars represent SEM.
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Figure 2.11. Following frequency analysis of CS and slo∆6b stocks. The
following frequency (FF) of the giant fiber pathway was determined using
stimuli sets consisting of three trains of 10 suprathreshold pulses (5 V over
the short-latency threshold) at 40-220 Hz. A) Representative traces of
short-latency recordings from the flight muscle DLM after 100 Hz and 160
Hz stimuli. B) The average FF50 was induced by BA sedation in both
strains. C) The mutant showed a bigger drug-induced FF50 enhancement.
















































Figure 2.12. Rhythmicity of the slo∆6b allele was strengthened. A)
Rhythmic activity of CS, slo∆6b and slo4 flies. Recently eclosed flies were
entrained in LD for 3 days before being transferred to DD and monitored
for 6 days. Both CS and slo∆6b flies demonstrated rhythmic oscillation in
activity and sleep. The slo∆6b mutant demonstrated higher peak activity
compared to CS. However the loss-of-function mutant of slo4 was
behaviorally arrhythmic. B) The slo∆6b strain displayed similar average
daily activity as CS, however, the loss-of-function mutant slo4 showed
enhanced activity. C) The percentage of flies that were identified as
rhythmic. D)The slo∆6b mutation did not affected the length of period.
Student's t-test and one-way ANOVA with Dunnett's post hoc test, *P ≤














































































Figure 2.13. Cycling of neural slo message in slo∆6b and CS. The graph
shows the circadian pattern of relative neural slo expression within two
days under free-running conditions. These time points have been shown to
be associated with highest or lowest neural transcription of slo89. Relative
slo mRNA abundance of CS (blue) and slo∆6b (red) was determined by RT-
real time PCR and was plotted as mean ± SEM. Statistic significance was
determined by two-way repeated measures ANOVA, n = 3.

























Drosophila stocks were Canton S (wild type), slo∆6b and slo4. Flies were raised on
standard cornmeal medium in a 12/12 light/dark cycle at 22°C. Newly eclosed flies
collected during a 2 d time period were studied 4-5 days after eclosion.
Ends-out gene targeting of the 6b element
The 6b deletion construct
The two flanking DNA fragments of the slo 6b element were amplified by PCR
with Canton S genomic DNA template and proofreading PfuTurbo DNA polymerase
(Stratagene CA) and inserted into the ends-out vector pW2595. Primers 5'-
GCGGCCGCGAGGGATGCTGCTGCTTTAC-3' and 5'-GCGGCCGCATTCTCGCCG
TTTTTAAATTCTCAG-3' were used in the PCR to amplify and add NotI sites to both
ends of a 3.26-kb DNA fragment upstream of the 6b element, while primers 5'-
GGCGCGCCTTGACACGCTTGCTTTTCCGGCTA-3' and 5'-GGCGCGCCAAGTT
GGCCCAGTTTGTTTG-3' were designed to amplify and add AscI termini to a 3.03-kb
DNA fragment downstream of 6b. These two donor fragments were then inserted into the
corresponding sites of pW25 with the same orientation. The pW25 vector also contains a
white+ gene between the two inserts.
Generation of the donor insertion lines
The 6b deletion construct was introduced into white background by standard P
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element germline transformation. All the insertion lines are mapped for the location of
the donor transgene, and lines with the donor transgene on the first or the second
chromosome were utilized to induce targeting.
Crosses and heat shocks
The scheme of 6b targeting was shown in Fig. 2.1. To induce targeting, donor
insertion lines are crossed to the P{hsp70FLP}P{hsp70I-SceI} strain (Bloomington #
6934). The progeny were heat-shocked during the first 3 days of development to induce
transgenic FLP and I-SceI . The heat shock was conducted by submerging fly vials into a
water bath kept at 38°C for 1 h. Virgin females with donor and P{hsp70FLP}P{hsp70I-
SceI} are collected and crossed to male FLP flies (Bloomington # 6938), and the progeny
are screened for solid red eyes. The white+ gene was mapped to identify targeting events
in which white+ was relocated to the target chromosome 3. And Southern blotting was
carried out to confirm targeting events occurred exactly in the designed position. Finally,
the targeted strain was crossed to P{Cre} line (Bloomington # 1501) to remove the white+
maker and obtain the 6b deletion mutant slo∆6b.
Southern blot analysis
Southern blot analyses were performed to verify the ends-out targeting events
using a DIG kit (Roche Diagnostics, IN) as recommended by the manufacturer. Genomic
DNA was prepared from targeted allele and wild type, followed by overnight digestion
with BsoBI (NEB, MA), agarose gel electrophoresis and nylon membrane transfer as
described96. The probe DNA in use was a 0.6 kb fragment in the 3' inert prepared by PCR
44
with primers 5'-GCGACCACAAATCGTCCAAACACA-3' and 5'-TAGCACTGCGAAC
TATCGCTGGAA-3'. The blot was hybridized to the digoxigenin (DIG) labeled probe
and was detected by DIG antibody and chemiluminescence signal.
Benzyl alcohol exposure
Recently eclosed female flies were distributed into multiple groups of 10. The 30
ml glass vials were coated with 200 µl of 0.4% benzyl alcohol in acetone, followed by
constant rotation for 20 min to evaporate the highly volatile acetone and leave a finely
distributed thin layer of less volatile benzyl alcohol on the wall. In contrast the vials for
controls were coated with acetone only, which was completely evaporated after 20 min.
Animals were transferred into the either the benzyl alcohol vials or the control vials until
all the flies in the drug vials were completely sedated (usually 5-10 min). After exposure,
flies were moved back to food vials for recovery.
Tolerance assay
Tolerance assay was performed as described before with minor modifications 13.
Recently eclosed female flies were divided into 12 groups of 10. In the first exposure, six
groups were sedated with 0.4% BA, and the others were mock sedated with acetone. On
the day of assay, all groups were sedated with 0.4% BA, and then were transferred to
fresh vials to recover. Flies were scored as recovered when they resumed climbing. The
whole course of recovery was analyzed by a computer controlled automated movement
detection system developed in our lab97. The recovery curves were plotted according to
the percentage of recovered flies against time. The log-rank test was used to determine
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significance between curves. Error bars represent the SEM for each individual data point.
Log-rank test
The log-rank test for equality of survival was used to determine the significant
difference between two recovery curves from the tolerance assay. The log-rank test, also
named the Mantel-Cox test, is a nonparametic hypothesis test to compare the survival
distributions of two groups at each observed event time. The analysis bases on the times
of events. For each observed event time point, the expected number of events were
calculated based on the observed number of events given there is no difference between
the two recovery curves, and then were added up to obtain the overall number of
estimated events. The statistic of log-rank test is the sum of (O-E)2/E for each group,
where O and E represent the total number of the observed and expected events,
respectively. The test statistic was compare with a χ2 distribution with 1 degree of
freedom to obtain the significance98,99.
Chromatin immunoprecipitation assay
About 1,500 slo∆6b flies were either benzyl alcohol sedated or mock sedated for
6-8 minutes and were allowed to recover in a drug free environment. Six and twenty-four
hours after sedation, flies were frozen in liquid nitrogen, and fly heads were harvested by
vortex decapitation and sieving. Heads were cross-linked with 2% formaldehyde for 3
min and chromatin was solubilized and sonicated on ice by 5 sections of 25 s sonication
bursts to produce fragments of ~600 bp using a sonic Dismembrator 250 (Fisher
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Scientific).
The chromatin immunoprecipitation (ChromIP) assays were performed as
described68. The polyclonal antibodies against acetylated histone H4 at K5, K8, K12 and
K16 (Upstate Biotechnology catalog # 06-866) was used to precipitate DNA. Chromatin
immunoprecipitation assays were performed more than three times with independent
chromatin samples.
Real time PCR analysis
Real time PCR was performed using the ABI SYBR Green PCR Master Mix.
Primers were designed to amplify 100~200 bp fragments at specific regions of the slo
transcriptional control region, including the two neural promoters (C0, C1), muscle
promoter (C2) and five evolutionarily-conserved areas (4b, 6b, cre1, 55b, cre2). Genes
Gpdh and Cyp1 were used as internal controls because neither of their expression was
affected by benzyl alcohol sedation68. Primers are: C0 (5'-ATCGAACGAAGCGTC
CAG-3', 5'-CGACGCGCTCAAACG-3'); 4b (5'-GACCCGATGATAAAGTCGATGT-3',
5'-GCCAGTGACTGACTGACACACA-3'); 6b (5'-CCAGCAGCAATTGTGAGAAA-3',
5'-CGAAGCAGACTTGAAAGCAA-3'); lox (5'-AAACGGCGAGAATGCGGC-3', 5'-
TCAAGGCGCGCCCTAGACT-3'); C1 (5'-ACAAACCAAAACGCACAATG-3', 5'-
AATGGATGAAGGACTGGGAGT-3'); cre1 (5'-GATGGGAAAGCGAAAAGACAT-3',
5'-CATGTCCGTCAAAGCGAAAC-3'); 55b (5'-TACCCAATTGAATTCGCCTTGTCT
T-3', 5'-CCCACTCTCCGGCCATCTCT-3'); C2 (5'-GCACTCGACTGCACTTGAAC-3',
5'-AATGAAAAAGTTCTCTCTGTGCAT-3'); cre2 (5'-TGGATTGCGACCGAGTGTCT
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-3', 5'-ATCAATACGATAACTGGCGGAAACA-3'); Gpdh (5'-GCATACCTTGATCTT
GGCCGT-3',5'-GCCCTGAAAAGTGCAAGAAG-3'); Cyp1 (5'-TCTGCGTATGTGTG
GCTCAT-3', 5'-TACAGAACTCGC GCATTCAC-3').
Real time PCR amplifications were run in duplicate, and the dissociation/melting
curves were used to detect nonspecific amplifications. The relative amount of the DNA
precipitated by the H4Ac antibody was determined by ∆∆Ct method. Fold enrichment of
H4 acetylation of drug-sedated group equals 2^(∆Ctctrl - ∆CtBA), where ∆Ct = CtIP - CtInput.
The entire protocol has been repeated at least three times and the mean and SEM were
calculated. Statistical significance was determined by the one-way ANOVA test.
Quantitative RT-PCR analysis
RNA was extracted from heads as described13. Reverse transcription and real time
PCR were performed in triplicate with slo exon C1, C2 and Cyclophilin 1 (Cyp1)
primers47. Relative RNA quantity was calculated using the standard curve method
(Applied Biosystems manual). Significance was calculated using the Student's t test.
The primers used are shown as follows: slo exon C1 forward primer 5'-
AAACAAAGCTAAATAAGTTGTGAAAGGA-3'; slo exon C1 reverse primer 5'-
GATAGTTGTTCGTTCTTTTGAATTTGA-3'; Cyp1 forward primer 5'-ACCAACCAC
AACGGCACTG-3; Cyp1 reverse primer 5'-TGCTTCAGCTCGAAGTTCTCATC-3'.
RNA time-course
To survey the cycling of slo, Newly eclosed CS and slo∆6b flies were entrained for
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5d in a 12/12 light/dark cycle at 22°C. Animals were collected and immediately frozen in
liquid nitrogen at the following Zeitgeber time: ZT4, ZT16, ZT28 and ZT40. These time
points have been shown to be associated with highest or lowest neural transcription of
slo89. RNA was purified from fly heads and the relative amount was determined by
quantitative real-time RT PCR.
Climbing assay
The climbing assay was conducted as described to measure relative activity of
flies100. Three groups of 12 flies each were placed in a 20 × 150 mm glass test tube, and
gently tapped to the bottom. The number of flies that climbed beyond 10 cm within 10
sec was counted. The experiment was repeated three times. Statistical significance
between percentages of flies passed the test was calculated using the Student's t test.
Flight assay
The flight capacity of animals was determined with minor modifications as
described101. Approximately 500 flies were dumped into a 15 × 62 cm pipette jar through
a funnel at the top. The falling flies flew toward the wall and were stuck in the mineral oil
pre-coated on the wall. The position of each fly was marked and its distance from the top
was measured. Flies with good flight capacity clustered near the top of the jar, where flies
flew poorly stayed close to the bottom.
Sticky-feet behavioral assay
The sticky-feet behavioral test was performed as described with minor
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modifications101. Flies of 4-5 days old were heat-shocked in a glass vial incubated at 37°C
for 7 min. After that, animals were gently transferred to the benchtop and left undisturbed
for about 10 sec. And a flat toothpick was used to poke flies on the side. The sticky-feet
phenotype is identified when a fly hold onto the surface instead of flying/moving away.
Circadian rhythm analysis
Flies were raised in a rhythmic 12:12 light:dark cycle. Male flies (aged 4-6) were
individually loaded, without anesthesia, into 5 mm × 65 mm glass tubes with 5% sucrose
2% agar food at one end. These tubes were then loaded into DAM2 Drosophila Activity
Monitors (Trikinetics, Waltham MA) that have infrared beams that detect when a fly
crosses the middle of the tube. The monitors are then placed into an incubator kept at
24°C. At the end of the light cycle after the flies are placed into the incubator, the lights
are permanently turned off to observe free-running rhythms. Flies were monitored in 5-
min bins for 14 days. At the end of this time period, any fly that did not move for any 24-
hour period in the first ten days was discarded from analysis. Circadian analysis was
analyzed using a Matlab software102. Only the first week of activity was analyzed. Plots
showing movement over time are created by averaging movement from flies from each
genotype. Period and rhythm indices are generated by the autocorrelation component of
the software. Sleep bouts were assumed to be when a fly did not cross the beam for five
minutes.
Electrophysiology analysis
An adult female fly was fixed on wax mount on a stereoscope stage. Tungsten
50
wire electrodes (FHC Inc) sharpened to approximately 5-µm diameter were inserted in
the fly using micromanipulators (Narishige). Two 200-µm diameter insulated tungsten
wire electrodes was inserted through each of the compound eyes. A 75-µm diameter
recording electrode was pierced through the dorsal cuticle into the upper DLM. A 200-
µm diameter reference electrode was placed on the abdomen. Stimuli were generated
using a S48 square pulse stimulator, isolated with a SIU5 Stimulus Isolation Unit (Grass-
Telefactor). Responses from the DLM muscles were amplified with a Microelectrode
Amplifier Model 1800 (A-M Systems), digitized by a DigiData 1200 (Axon instruments)
and recorded in a PC using FETCHEX, pCLAMP 6 software (Axon instruments).
Seizure susceptibility measurement
Seizure threshold was measured utilizing the giant fiber (GF) pathway as
described53. A 1.5-s long 200 Hz ECS pulse of various voltage was used to trigger seizure
in the animal. A seizure was recognized as a high frequency initial discharge, followed by
a prolonged failure period and a delayed secondary pulse. The minimum voltage of
stimulation to trigger seizure was determined as seizure voltage threshold of the fly.
Determination of neuronal following frequency
The following frequency of the giant fiber pathway was determined as
described53. To determine the threshold of giant fiber pathway, a fly received single 0.1-
µs pulses of increasing voltage at 5-s intervals to induce DLM response. Then the latency
to the responses after the stimulation was measured. The voltage amplitude of the stimuli
was increased until a response with a constant short latency of 1.4 ms was detected. The
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following frequency was determined using stimuli sets consisting of three trains of 10
suprathreshold pulses (5 V over the short-latency threshold) at 40-220 Hz. Flies were
allowed to rest for 5 s between each stimulus train and 15 s between each train set to
protect animals from exhaustion. The number of responses detected in the muscle were
plotted against frequency to generate a frequency-response curve. Statistical significance
was determined by two-way repeated measures ANOVA.
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Chapter 3: 55b regulates muscle-specific slo expression
Introduction
The slo gene encodes the BK-type voltage- and Ca2+-activated K+ channel that
plays important roles in shaping action potential and regulating neuronal excitability, in
regulating firing pattern and synaptic transmission, and in the control of smooth muscle
tone19-22. Recently slo has been implicated in the homeostatic response after anesthetic
drug sedation that enhances the activity of the nervous system to balance out drug effects
and thus lead to the development of functional tolerance (reduced responsiveness to an
effect of a drug caused by prior drug exposure). However, after drug clearance, the same
enhancement in BK channel activity persists, thus producing withdrawal symptoms,
including enhanced seizure susceptibility53. Flies are ideal for the study of functional
tolerance as they do not develop metabolic tolerance to organic solvents (increased rate
of clearance)53,85. We have shown that the upregulation in neural slo expression is both
necessary and sufficient for the development of drug-induced tolerance in Drosophila13,46.
The slo gene and its role in the response to anesthetic solvents are highly conserved
between flies and other eukaryotes, such as C. elegans and mammals81-83. For example,
microRNA-regulated expression of slo BK channels has been shown to underlie
physiological ethanol tolerance in the rat hypothalamo-neurohypophysial explant
system84.
The Drosophila slo gene is regulated by alternative promoter activation and
alternative RNA splicing, which altogether, allow cells to customize BK channels with
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fine-turned conductance and calcium sensitivity to meet their particular needs. The slo
gene has a complex 7 kb transcriptional control region, containing at least five promoters
that mediate developmental and tissue-specific expression. It also contains 14 alternative
exons distributed among five alternative splicing sites27,29-31,103.
The DNA elements 6b and 55b are short evolutionarily conserved DNA elements
of slo identified by sequence homology analysis among multiple Drosophila species27,103.
A single anesthetic benzyl alcohol sedation has been shown to induce dynamic
spatiotemporal changes of histone H4 acetylation across the slo transcriptional control
region. The earliest histone acetylation peak is identified over the 55b element 4 hr after
drug exposure. Six hours after sedation, the 6b element and the two neural promoters (C0
and C1) are associated with enhanced histone acetylation. This correlates with induction
of neural slo message and behavioral tolerance. By 24 hr, enhanced acetylation is only
observed at the 6b element. By 48 hr, both histone acetylation level and slo message
abundance have returned to baseline. In addition, administration of a universal HDAC
inhibitor sodium butyrate causes hyperacetylation across the slo control region, induces
slo transcription and phenocopies tolerance68. Histone acetylation is a common early step
in gene activation and plays an important role in drug addiction104,105. These data suggest
the potential role of the 55b element as a key element that initiates the activation of the
slo gene after drug sedation.
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Results
Generation of the 55b deletion mutant
To address the in vivo role of 55b, we created a knockout mutant of this DNA
element by homologous recombination based ends-out gene targeting106. In brief, the 55b
element was substituted by a mini-white+ marker from a donor transgene through
homologous recombination to obtain the slow∆55b allele. To verify targeting events,
Southern blot analysis was performed using a DIG labeled probe specifically recognizing
the 3 kb upstream DNA sequence of 55b. As shown in Fig. 3.1, DNA from wild type
(lane 1) showed a 5.6 kb fragment; while DNA from slow∆55b homozygotes (lane 2-5)
exhibited a 4.3 kb band. The mini-white+ marker gene was later excised through Cre/lox
recombination to eliminate the transcriptional effects of the transgene, and the derived
slo∆55b allele was backcrossed to wild type (CS) flies for six generations for a more
isogenic background. The slo∆55b homozygotes are healthy animals showing normal
growth rate and development.
slo∆55b did not affect drug-induced epigenetic responses.
The 55b element has the earliest benzyl alcohol-induced histone H4 acetylation
peak68. We hypothesized that the cis-acting element 55b is an important regulator of the
slo gene, probably by acting as the initiator of drug-induced histone acetylation
modifications across the slo regulatory region. If this hypothesis is correct, then loss of
55b should prevent slo induction, the post-sedation histone acetylation pattern associated
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with drug induction of slo, and the production of behavioral tolerance. The abundance of
slo message in slo∆55b flies was quantified by real-time RT-PCR using primers specifically
recognizing all the neural splicing variants. In contrast to our expectation, we found that
the 55b deletion did not affect the magnitude and time-course of neural slo induction after
drug sedation nor did it affect the basal level of neural slo expression. Furthermore, in
both the mutant and wild type lines, the induction of slo transcription had a normal time-
course. Induction was detected 6 h after drug sedation and had disappeared by 24 h post
sedation (Fig. 3.2).
To investigate if 55b is responsible for the subsequent acetylation changes of the
slo transcriptional control region, ChromIP was performed in slo∆55b using an antibody
specific for histone H4 acetylation to separate chromsosomal fragments with H4 histone
highly acetylated, and real-time qPCR was utilized to quantitate those fragments. In the
wild type, we detected enhanced histone acetylation at neural promoter C1, the DNA
elements 6b and 55b four hours after benzyl alcohol sedation, while promoter C0 showed
mildly increased acetylation (not significant). In the slo∆55b mutant hyperacetylation was
found at C0, C1 and 6b at 4 h post sedation. By 6 h, acetylation peaks were found at C0,
6b and C1 in both the wild type and the mutant. By 24 h, only the 6b element showed a
significant histone acetylation spike in the wild type, whereas in mutant histone
acetylation levels had returned to the baseline level (Fig. 3.3). Based on these data, it
seems that the 55b element is not required for subsequent drug-induced histone
acetylation across the slo promoter region. These data indicates that the 55b element is
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not a trigger for the later histone modifications.
slo∆55b did not affect drug-induced tolerance and withdrawal phenotype.
Induction of a neural-specific slo splice variant has been shown to produce
resistance to benzyl alcohol and ethanol13,47, suggesting that the expression of slo in the
nervous system is essential for drug resistance. Our lab has also shown that the increased
expression of slo leads to the reduction of the neural refractory rate and the enhancement
of seizure susceptibility that are believed to lead to withdrawal symptoms53. However, it
is possible that drug resistance and tolerance are controlled by specific brain region and
the 55b mutation could only affect the small subset of neurons that regulate these
behaviors. Therefore, the mutant was subjected to different drug-related behavior tests.
Here resistance and tolerance describe different drug phenotypes. The former
demonstrates the baseline magnitude of drug responsiveness that affects drug
consumption and contributes to drug addiction107, while tolerance is believed to be a
homeostatic response of the nervous system that enhances neuronal activity to counteract
the sedative effect of the drug13. 
At first, the mutant was assayed for resistance to anesthetic benzyl alcohol. Age-
matched female flies of CS and slo∆55b were exposed to a sedating dose of benzyl alcohol
for the first time. These animals became hyperactive, uncoordinated and eventually
sedated. Then animals were allowed to recover in a drug-free environment, and the rate
of recovery was used as an indicator of drug resistance. Both the mutant and wild type
flies recovered at the same rate, suggesting the slo∆55b mutation did not affect resistance to
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benzyl alcohol (Fig. 3.4). Next, the mutant was assayed for the capacity to acquire
tolerance. Age-matched CS and slo∆55b flies (4 days post-eclosion) were sedated with
benzyl alcohol, allowed to recover and then stored on food for 1 d, 7 d and 14 d before
being tested for the functional tolerance. To test for functional tolerance, the flies were
then sedated a second time and their period of sedation measured. Stocks were
recognized to be capable of acquiring tolerance if they recovered more rapidly from the
second sedation than from the first sedation. As shown in Fig. 3.5, slo∆55b acquired
tolerance to benzyl alcohol (left shifted recover curve), and tolerance in the mutant lasted
for 7 days, as in the wild type. These results suggest 55b does not affect the acquisition or
the duration of tolerance to benzyl alcohol sedation.
Resistance and tolerance describe different drug phenotypes. The former
demonstrates the baseline magnitude of drug responsiveness, while tolerance indicates
the drug-induced reduction in responsiveness. Resistance to the sedating/intoxicating
effects of anesthetic drugs affects drug consumption and contributes to drug addiction107.
Induction of a neural-specific slo splice variant has been shown to produce resistance to
benzyl alcohol and ethanol13,47, suggesting that the expression of slo in the nervous
system is essential for drug resistance. Ablation of the 55b element did not affect
resistance to benzyl alcohol or change the basal neural slo expression.
Drug-induced slo expression acts as a neural excitant that accelerates neural
excitability to counter the sedative effects of the anesthetic. However, after drug
clearance, the slo-induced increase in excitability persites to generate withdrawal-related
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behavioral changes. These include increased capacity for repetitive neuronal firing and
enhanced seizure susceptibility53. Here we looked at these drug withdrawal-related
phenotypes utilizing the giant fiber (GF) preparation. To investigate whether the mutation
alters drug-induced effects on the refractory period of the giant fiber pathway, we
measured the giant fiber following frequency. Trains of stimuli at various frequencies
ranging from 40 to 220 Hz were delivered to the brain and responses in the flight muscle
were recorded. The giant fiber circuit fails to respond when the interval between the
individual stimuli is less than the refractory period of the GF neurons. We found that the
FF50 (the frequency with 50% response rate) of GF pathway of the mutant and wild type
had the same baseline levels, and both were significantly increased 24 h after benzyl
alcohol sedation (Fig. 3.6A).
To further characterize the neural excitability of the flies, trains of high frequency
electroconvulsive shocks (ECS) of various voltages were delivered to the brain to trigger
a seizure-like electrical response, and the minimum triggering voltage was recorded as
the seizure threshold. The seizure-like phenotype was characterized as a high-frequency
spontaneous initial discharge followed by a failure period to the response and a delayed
secondary discharge (Fig. 3.6B). The average seizure stimulus voltages in the mutant and
wild type flies were measured before and after BA sedation. Without drug exposure, the
slo∆55b flies exhibited an average threshold of 33.18 ± 3.182 V, while the stimulating
voltage dropped to 21.88 ± 2.98 V one day after benzyl alcohol sedation. The wild type
showed similar responses, suggesting that the mutation does not affect basal seizure
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susceptibility or drug-induced seizure susceptibility enhancement.
The 55b mutation enhanced basal mobility and the muscle expression of slo.
In Drosophila, the muscle-specific expression of BK channels is regulated by the
C2 promoter that is only 300 bp downstream of the 55b element, thus the 55b element
might play a role in the regulation of slo expression in muscle. To test this hypothesis, we
conducted real-time RT-PCR using primers specific recognizing the muscle splice
variant. We found that the slo∆55b mutant exhibited significantly enhanced basal muscle
slo expression compared to wild type (Fig. 3.2D). However, in contrast to the
transcriptional regulation of slo in the nervous system, drug exposure did not further
induce muscle slo expression in both lines (Fig. 3.2E-F).
Basal mobility is an important indicator of normal physiological performance, and
is affected by genotype, age, gender, nutrition, temperature and circadian factors, etc.
Here we conducted a ten minute walking test to determine if the slo∆55b mutation
increased mobility. As shown in Fig. 3.7A, the walking distance was significantly
induced in slo∆55b mutant, while another slo DNA element deletion mutant (slo∆6b)
traveled the same distance as the wild type, suggesting the change of basal mobility is
specific to the 55b element.
However, the slo∆55b mutation did not affect all the locomotor activities we tested.
The 55b deletion did not affect climbing and flight capacity, while the null mutant slo4
showed disturbed activity in both tests (Fig. 3.7B, C). Like the wild type CS, The slo∆55b
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line also displayed rhythmic behaviors in locomotor activity. However, the null mutant
slo4 was completely arrhythmic (Fig. 3.7D).
Discussion
Recent studies have shown that histone acetylation of the slo promoter region is
involved in drug-induced slo gene up-regulation and the development of tolerance. The
evolutionarily conserved DNA element 55b is the region associated with the enhanced
acetylation peak as measured in a ChromIP time-course assay 4 h after benzyl alcohol
sedation68. However, in our measurement, promoter C1 and the 6b region were also
recognized as hyper-acetylated at the same time point (Fig. 3.3B). This difference may
result from the variability between wild type stains being utilized, or from changes in
experimental conditions such as age and batch of reagent. As to the other two time points
being examined, 6 h and 24 h after sedation, our results are in great agreement with
previous observations68. These conserved results prove the ChromIP-qPCR to be an
effective and robust method to capture the epigenetic properties in Drosophila.
The slo transcriptional control region also contains two putative cAMP responsive
element (CRE) binding sites, which are indicated as cre1 and cre2. Moreover, a putative
AP-1 binding site is present in the 55b element. The CRE sites and AP-1 sites share
consensus DNA sequences, and their specific recognizing proteins, CREB and c-jun,
have been shown to be able to dimerize and bind to the AP-1/CRE-like binding site108.
Furthermore, the CREB transcription factor has been shown to be responsible for these
drug-induced changes. It has been shown that benzyl alcohol sedation enhances the
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occupancy of activated CREB in the slo regulatory region, while activation of a CREB
dominant-negative transgene blocks hyperacetylation at slo regulatory regions, prevents
slo message induction and ablates tolerance68,69.
The slo∆55b mutation enhanced basal muscle slo expression, thus leading to an
increased mobility relative to wild-type background. However, benzyl alcohol sedation
did not further induce muscle slo expression. Based on these results, the 55b element is
likely to be a transcriptional repressor for muscle specific slo expression and furthermore,
this repressor is not affected by drug exposure. Interestingly, the mutation did not affect
other locomotor activities, including climbing, flying, and circadian rhythmicity. Also
these flies did not exhibit the "sticky-feet" phenotype. However, a slo null mutation
results in reduced flight capacity, loss of circadian rhythmicity and a "sticky-feet"
phenotype89,92. These results suggest walking activity is more sensitive to muscle slo
expression.
The 55b element contains multiple putative transcription factor binding sites,
including a TGIF binding site (Fig. 3.8). TGIF is a DNA-binding homeodomain protein
that acts as a multifunctional transcriptional repressor, and the transcriptional repression
by TGIF in part depends on the activity of HDAC109. TGIF has been shown to compete
with p300 for interaction with Smad2 that forms a complex with Smad4 upon TGFβ
receptor activation. The Smad2-Smad4 complex binds to target promoters and recruits
co-activators such as p300/CBP or co-repressors such as TGIF110. The 55b element also
contains a putative site for StuAp that is a transcriptional repressor characterized in
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Aspergillus nidulans111. These binding motifs may contribute to the repressing effects of
the 55b element.
Two putative AP-1 sites are also detected in the 55b region. AP-1 (activating
protein-1) family of transcription factors consists of homodimers or heterodimers of
subunits from Jun (c-Jun, v-Jun, JunB and JunD), Fos (c-Fos, v-Fos, FosB, Fra1 and
Fra2) or ATF (ATF2, ATF3/LRF1 and B-ATF) that interact through a leucine zipper
motif and bind to the recognition DNA element via a basic DNA contact region112. Both
AP-1 and CREB transcription factors transduce environmental signals into alteration in
expression of specific target genes. AP-1 and CREB also share similarities in molecular
properties and activation mechanisms, and CBP is required for the activation of both of
them113,114. Moreover, it has been shown that members from the two families can form
cross-family heterodimers115, and cross-talk between the two families can occur as CREB
has been shown to bind to AP-1 sites116.
Our lab has shown the occupancy of CREB at the 55b element and two CRE sites
is enhanced by benzyl alcohol sedation68. However, the 55b element does not contain any
CRE sites, thus CREB protein is thought to interact with the 55b element via the AP-1
site. Upon binding to these DNA elements, CREB may stimulate slo expression via
recruiting the co-activator CBP that has intrinsic HAT activity117. By activating histone
acetylation, CBP induces chromatin accessibility and facilitates the docking of
transcription machinery. CREB has been shown to be required for the induction of slo
and for the development of tolerance68. However, ablation of 55b did not abolish slo
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induction or tolerance, suggesting that the occupancy of the two CRE sites by CREB is
critical for drug-induced slo regulation and tolerance. Thus the 55b element is not
required for drug-induced slo activation and the development of tolerance.
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Figure 3.1. Southern blot analysis of the 55b targeting event. A) The
digestion map of slo regulatory region in wild type and the targeted
mutant. Genomic DNA was digested with HindIII and blotted to a
membrane that was detected with a 3.1 kb probe shown as the 5'-
homologous fragment. A 5.6 kb fragment was recognized in the wild type,
while a 4.3 kb band was recognized in the slow∆55b targeted mutant. B) The
Southern blot analysis. Lane 1, DNA from the wild type fly showing a 5.6
kb fragment; lane 2-5, DNA from homologous targeted alleles showing a






















Figure 3.2. Analysis of slo transcription in the nervous system and muscle.
A) Relative neural slo expression levels in slo∆55b and wild type,
determined by real-time RT-PCR using C1 primers that only amplify
neural slo transcripts. B-C) The ratio of slo message abundance after drug
sedation over untreated control. D) The slo∆55b flies displayed enhanced
basal muscle slo message expression compared to the wild type. The slo
mRNA levels of the muscle were determined by real-time RT-PCR using
C2 primers that only amplify muscular slo transcripts. E-F) The muscle slo
transcription in both mutant and wild type were not altered by drug
sedation. Statistical significance was determined by Student's t-test; *P ≤
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Figure 3.3. Patterns of histone H4 acetylation across slo transcriptional
control region in slo∆55b after benzyl alcohol sedation. A) Map of slo
control region. B) H4 acetylation levels at 4 h after BA sedation detected
by ChromIP and real-time PCR. Fold change of acetylation was the ratio
of the acetylation levels of drug-sedated flies over untreated ones. C)
Acetylation levels at 6 h after BA sedation. D) Acetylation levels at 24 h
after BA sedation. Statistical significance was determined by one-way
ANOVA with Dunnett's comparison post tests (n = 3, *P ≤ 0.05). Error
bars represent standard error of the mean (SEM).
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Figure 3.4. The 55b deletion mutation did not affect resistance to benzyl
alcohol sedation. To test the resistance to anesthetic benzyl alcohol, age-
matched female flies of both CS and slo∆55b were exposed to a single
sedating dose of benzyl alcohol. After that flies were transferred to fresh
vials to recover. The percentage of recovered flies over time was plotted.
Both CS and slo∆55b flies recovered at the same rate. The statistical
significance between the two recovery curves was determined by log-rank
test and error bars represent SEM.




















Figure 3.5. The 55b deletion mutant acquired normal tolerance to benzyl
alcohol induced sedation. The tolerance assay shows that slo∆55b flies
acquired tolerance to benzyl alcohol. The tolerance was also detected by 7
d after the first exposure, but disappeared by 14 days. CS wild type was
utilized as a control showing tolerance with normal duration. On the day of
treatment, age-matched female flies were either drug sedated or mock
sedated. On the day of assay, all the flies were sedated completely with
anesthetic benzyl alcohol, the recovery process was monitored and the
recovery curves were plotted. The curve shows the percentage of
recovered flies from their first sedation (blue) and the second (red) drug
exposure over time. The statistical significance between the two recovery
curves was determined by log-rank test. *P ≤ 0.05.














































































































Figure 3.6. Drug sedation caused similar electrophysiological changes in
slo∆55b and wild type flies. A) Drug sedation increased following frequency.
B) Drug sedation enhanced seizure susceptibility in both lines.
Electroconvulsive stimuli of varying voltages ranging 5-50 V were utilized
to determine seizure susceptibility, which is represented by the minimum
stimulus voltage to trigger seizure. The average stimulus voltages in wild
type and slo∆55b measured one day after BA sedation. BA sedation reduced
stimulus voltage in both stocks. Unpaired t-test, n = 5~9, *P ≤ 0.05. Error
bars represent SEM.
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Figure 3.7. The slo∆55b mutation did not affect all the locomotor activities.
A) The slo∆55b mutant exhibited enhanced walking distance compared to
CS wild type and slo∆6b in a 10 min free walking test. B) The slo∆55b flies
showed normal climbing ability. Flies that climbed beyond 10 cm within
10 sec were considered as passing the climbing assay. Over 95% of CS and
slo∆55b flies passed the climbing test, whereas only 30% of the loss-of-
function mutant slo4 stock passed it. C) The slo∆55b mutation did not affect
flight capacity. Flies were dropped into a 15 × 62 cm pipette jar at the top.
The falling flies flew toward the wall and were stuck in the mineral oil pre-
coated on the wall, and the distance from the top was measured. Wild type
and slo∆55b animals fly well, and most of them are found within 10 cm to
the top. In contrast slo4 flies flew poorly and were evenly distributed along
the wall. D) Rhythmic activity of CS, slo∆55b and slo4 flies. Recently
eclosed flies were entrained in LD for 3 days before being transferred to
DD and monitored for 6 days. Both CS and slo∆55b flies demonstrated
rhythmic oscillation in activity, while slo4 was behaviorally arhythmic.
One-way ANOVA with Dunnett's post hoc test was used to determine the
















































































Figure 3.8. Sequence analysis of the 55b element. The binding sites of
transcription factors within the 55b element were identified using
TRANSFAC database118. Transfactor binding sites are: AP-1, Activator
Protein-1; BR-C, Broad-Complex; E2F, Dl, Dorsal; Oct-1, Octamer
binding factor 1; SBF, Silencer-binding factor; StuAp, the Aspergillus
nidulans Stunted protein; TGIF, TG-interacting factor. The score describes
the quality of the match that ranges from 0 to 1.
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BRC (0.908) AP-1 (0.927) AP-1 (0.942)
Oct-1 (0.923) E2F (0.934)
S8 (0.987) Dl (0.944)





Drosophila stocks were Canton S (wild type), slo4 and slo∆55b. Flies were raised on
standard cornmeal medium in a 12:12 light:dark cycle at 22°C. Newly eclosed flies
collected during an interval of 2 days were studied 3-5 days after eclosion.
Ends-out gene targeting of the 55b element
The 55b element of slo was ablated using ends-out gene targeting method
developed by Golic and coworkers88. At first, the two homologous sequences flanking the
slo 55b element were amplified by PCR using Canton S genomic DNA as the template
together with a proofreading PfuTurbo DNA polymerase (Stratagene CA). More
specifically, primers 5'-GCGGCCGCCTCGGTGGTTTAGCCAGTA-3' and 5'-
GCGGCCGCGCCAAGACAAGGCGAATTCAA-3' were used in the PCR to amplify
and add NotI sites to both ends of a 3.1-kb DNA fragment upstream of the 55b element,
while primers 5'-GGCGCGCCAAATGCCCGTATAGTCATA-3' and 5'-GGCGCGC
CTAAAGACGCCCAGACAAATG-3' were designed to amplify and add AscI termini
to a 3-kb DNA fragment downstream of 55b. These two fragments were then inserted
with the same orientation into their corresponding sites that flank the white+ gene in the
ends-out vector pW2595. This construct, also called the donor construct, was introduced
into the white- fly by standard P element germline transformation. All the insertion lines
are mapped for the location of the donor transgene, and lines with the donor transgene on
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the first or the second chromosome were utilized to induce gene targeting.
To induce targeting, donor insertion lines are crossed to the
P{hsp70FLP}P{hsp70I-SceI} strain (Bloomington # 6934), and the progeny were heat-
shocked at 38°C for one hour during their first three days of development to induce
transgenic FLP and I-SceI which worked on their corresponding recognition sites in the
donor sequence. The donor sequence was hopped out from its insertion site in a circular
form under the action of FLP recombinase, and was linearized after I-sceI digestion.
These changes allow pairing and crossover between the homologous donor fragment and
the targeted 55b region. Thus that 55b was replaced by the white+ from the donor
sequence. Virgin females with white+ and P{hsp70FLP}P{hsp70I-SceI} are collected and
crossed to male FLP flies (Bloomington # 6938), and the progeny are screened for solid
red eyes. The white+ gene was mapped to identify targeted events in which white+ was
relocated to the target chromosome 3. And Southern blotting was carried out to further
confirm targeted events occurred exactly in the designed position. Finally, the targeted
strain was crossed to P{Cre} line (Bloomington # 1501) to remove the white+ maker and
obtain the 55b deletion mutant slo∆55b. The female slo∆55b fly was backcrossed to male
Canton S for six generations.
Southern blotting analysis
Southern blot analyses were performed to verify the ends-out targeting events
using a DIG kit (Roche Diagnostics, IN) as recommended by the manufacturer. Genomic
DNA was prepared from flies carrying the targeted allele and wild type, followed by
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overnight digestion with HindIII (NEB, MA), separated by agarose gel electrophoresis
and transferred to nylon membranes as described96. The probe DNA in use was the 3.1-kb
upstream homologous fragment of the 55b element. The blot was hybridized to the
digoxigenin (DIG) labeled probe and was detected by DIG antibody and
chemiluminescence signal.
Benzyl alcohol exposure and tolerance assay




A total of 12 age-matched female flies were monitored for mobility in a 12-well
cell culture plate (well diameter 35 mm, 5 mm high), with each animal in a separate well.
Humidified air was delivered through the plate to prevent dryness. After 5 minutes of
equilibration, the activity of the flies was recorded in a 10-min video using a computer-
controlled web camera place above the plate. The quantification of locomotor activity (in
walking speed) by video-tracking was performed as described119. Experiments were
performed at the same time of day to screen out the influence of circadian rhythms. Flies
tested were CS, slo∆55b and slo∆6b. Each assay was repeated three times and a One-way
ANOVA with Dunnett's post hoc test was used to determine the statistical significance.
Climbing assay, flight assay, Sticky-feet behavioral test and Circadian analysis
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The climbing assay, flight assay, sticky-feet behavioral test and circadian rhythm
analysis were conducted as described in Chapter 2.
Quantitative RT-PCR analysis
RNA was extracted from heads or the whole body. The quantitive RT-PCR was
conducted as described in Chapter 2. The primers used are shown as follows: slo exon C1
forward primer 5'-AAACAAAGCTAAATAAGTTGTGAAAGGA-3'; slo exon C1
reverse primer 5'-GATAGTTGTTCGTTCTTTTGAATTTGA-3'; slo exon C2 forward
primer 5'-GCTATTTATAATAGACGGGCCAAGTT-3'; slo exon C2 reverse primer 5'-
GGAAATCCGAAAGATACGAATGAT-3'; Cyp1 forward primer 5'-ACCAACCACAA
CGGCACTG-3; Cyp1 reverse primer 5'-TGCTTCAGCTCGAAGTTCTCATC-3'.
Chromatin immunoprecipitation assay
The chromatin immunoprecipitation (ChromIP) assays were performed as
described in Chapter 2.
Electrophysiology analysis
Seizure susceptibility and following frequency of the GF pathway were
determined as described in Chapter 2.
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Chapter 4: Histone acetylation in tolerance
Introduction
In Drosophila, the slo gene encodes the BK-type voltage- and Ca2+-activated K+
channel that is involved in the acquisition of functional tolerance to anesthetic drug
induced sedation. Tolerance is defined as the reduced responsiveness to an effect of a
drug caused by prior drug exposure1. It has been shown that neural slo expression is
necessary for the development of drug-induced rapid tolerance. A single sedating dose of
the anesthetic benzyl alcohol or ethanol induces the expression of slo in the nervous
system. Moreover, mutations ablating neural slo expression also block tolerance, while
activating a slo transgene that expresses a neural splice variant phenocopies tolerance13,46.
The Drosophila slo gene is regulated by alternative promoter activation and
alternative mRNA splicing, which lead to the functional diversity of BK channels. The
slo gene has a complex 7 kb control region, containing at least five transcriptional
promoters that mediate developmental and tissue-specific expression, including neural
specific promoters C0 and C1, the midgut promoters C1b and C1c, and the muscle
promoter C2 that regulates expression in the muscle and tracheal cells27. The slo gene
also contains five alternative splicing sites31. Theoretically, activation of slo expression
through such regulation can give rise to over 1000 distinct peptides31. Presumably,
alternative splicing allows cells to customize BK channels by fine-tuning conductance
and calcium sensitivity to meet their particular needs.
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A large number of evolutionarily conserved DNA elements and protein binding
motifs have been identified in the transcriptional regulatory region of slo. The DNA
elements 6b and 55b are short non-core promoter DNA elements recently identified by
sequence comparison between the twelve Drosophila species whose genome has been
sequenced27,103. The slo regulatory region contains two putative cAMP responsive
element (CRE) binding sites and a putative AP-1 binding site within the 55b element68.
The CRE sites and AP-1 sites have similar consensus sequences, and their specific
recognizing proteins, c-jun and CREB, have been shown to be able to dimerize and bind
to an AP-1/CRE-like binding site108.
Recently it was shown that benzyl alcohol exposure induces dynamic
spatiotemporal changes of histone H4 acetylation across the slo control region. Four
hours after drug sedation, an acetylation spike is observed over the 55b DNA element.
Two hours later, enhanced histone H4 acetylation has been observed at the 6b element
and across the two neural promoters (C0 and C1). During this time, neural slo message
abundance becomes elevated and behavioral tolerance can first be detected. Twenty-four
hours after sedation, slo message level decreases and H4 acetylation is only observed at
the 6b element. By 48 hr, both histone acetylation level and slo message abundance have
returned to baseline68.
Inducing histone acetylation with a universal histone deacetylase inhibitor, sodium
butyrate, causes hyperacetylation across the slo transcriptional control region, induces slo
transcription and phenocopies tolerance. The CREB transcription factor has been shown
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to be involved in these drug-induced changes. Benzyl alcohol sedation enhances the
occupancy of activated CREB in the slo regulatory region, while activation of a CREB
dominant-negative transgene blocks hyperacetylation at slo regulatory regions, prevents
slo message induction and ablates tolerance68,69.
The enhancement of histone acetylation by sodium butyrate is not confined to the
slo control region but also occurs elsewhere in the genome. While a functional slo allele
is required for sodium butyrate-induced resistance68, this does not exclude the possibility
that the hyperacetylation across the slo regulatory region may not reflect changes that are
required for or that cause drug-dependent induction of slo. Because of a lack of direct
evidence linking the state of histone acetylation across the slo control region to slo
induction and the acquisition of tolerance, I wished to specifically manipulate acetylation
within the slo transcriptional control region and to determine the effect on slo
transcription and the production of functional tolerance to benzyl alcohol sedation. To
achieve this goal, I tethered histone acetylation modifiers (an HDAC and a HAT)
adjacent to the 6b or 55b elements of the slo control region in order to artificially reduce
or enhance acetylation at the sites. These two DNA elements were chosen because their
hyperacetylation status is specifically altered following benzyl alcohol sedation68.
Tethering was performed by expressing a GAL4DBD-HDAC or GAL4DBD-HAT fusion
protein in flies in which a UAS sequence was inserted adjacent to either 6b or 55b. The
Gal4DBD domain is the DNA binding domain (DBD) of the yeast Gal4 transcription
factor. This DBD specifically binds to the UAS120.
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Results
To study the effect of localized histone acetylation at the 6b element and the 55b
element in the slo regulatory region, histone acetylation modifiers were docked at these
elements respectively through a binary Gal4-UAS expression system (Fig. 4.1). This
system is composed of two components: the DNA-binding domain of the yeast
transcription activator protein Gal4 and a short DNA sequence named upstream
activation sequence (UAS), to which Gal4 binds specifically. More specifically, a single
copy of the UAS was inserted 5' of the 6b and 55b elements by homologous
recombination to generate the slo6bUAS and slo55bUAS mutations. Southern blot analysis was
carried out to identify strains in which targeting had correctly occurred (Fig. 4.2). The
slo6bUAS and slo55bUAS stocks were individually crossed to stocks carrying three different
heat shock inducible Gal4 transgenes. They are the Gal4DBD-HDAC, Gal4DBD-HAT and a
Gal4DBD transgenes. The Gal4DBD-HDAC transgene expresses a hybrid Gal4 transcription
factor in which the GAL4 DNA binding domain (DBD) is fused to a HDAC domain from
transcription factor Rpd3/HDAC1. The Gal4DBD-HAT transgene expresses a hybrid Gal4
protein in which the DBD domain is fused to the HAT domain from transcription factor
Chameau/HAT1. The Gal4DBD transgene expresses a transcription factor that contains
only the Gal4 DNA binding domain (but not HDAC or HAT domain). Gal4DBD was used
as a control for the effect of binding an enzymatically-inactive protein at the UAS sites.
Expression of these transgenes is driven by a heat-inducible hsp70 promoter. Offspring
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from the crosses contain both the sloUAS allele and the inducible Gal4 derivatives.
Following heat induction, the modified Gal4 protein should bind to the inserted
UAS from where the tethered HAT or HDAC domain can modify the local histone
acetylation state. In this manner we should be able to determine whether acetylation at
these positions is sufficient for slo induction. In addition, we should be able to determine
whether acetylation at these positions is necessary for the response of slo to benzyl
alcohol sedation. A heat pulse is used to activate the hsp70 promoter that drives
expression of the Gal4-derived transgenes. Using this two-part system, the histone
modifiers will be tied to the 6b element or the 55b element in order to locally change the
histone acetylation level (Fig 4.1).
I also obtained ideal control animals for all the UAS knock-in lines from the
genetic crosses to induce homologous recombination. These control lines were isolated
when homologous recombination took place downstream of the UAS sequence of the
donor. Therefore the control lines, slo6bL and slo55bL, have the same genetic background as
the UAS knock-in lines, except for the absence of the UAS motif.
HS-GAL4DBD-HDAC; slo6bUAS females acquired tolerance to benzyl alcohol as long
as the HS-GAL4DBD-HDAC transgene was not activated (Fig. 4.3A). Moreover, resistance
to benzyl alcohol was unchanged in animals after heat shock induction of the HDAC
expressing transgene (Fig. 4.3B). However, activation of the HDAC transgene interfered
with the capacity of flies to acquire tolerance. Not only did the animals not acquire
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tolerance, but they instead showed sensitization to benzyl alcohol sedation when the
HDAC transgene was activated 24 h before the first benzyl alcohol exposure (left-most
panel of Fig. 4.3C). Tolerance was also blocked if the activating heat shock occurred 24 h
after the first drug exposure (left-most panel of Fig. 4.3D). In contrast, the HS-GAL4DBD-
HDAC; slo6bL control animals acquired tolerance to drug sedation whether the HS was
delivered 24 h before benzyl alcohol sedation or 24 h after benzyl alcohol sedation (right-
most panels of Fig. 4.3C & D, respectively).
In a parallel series of experiments using HS-GAL4DBD-HDAC; slo55bUAS females I
observed that activating the HDAC transgene 24 h before the first drug exposure blocked
tolerance (Fig. 4.4C) but did not cause sensitization as with slo6bUAS. However, activating
it after the 24 after the first drug treatment had no effect on tolerance acquisition (Fig.
4.4D). This latter result is in contrast to the slo6bUAS experiment (see above).
These data showed that tethering a HDAC adjacent to slo control elements
blocked tolerance to benzyl alcohol. The only difference between the UAS knock-in lines
and the controls is the insertion of a UAS motif adjacent to either the 6b or the 55b DNA
elements, and only activating the HDAC transgene in the UAS knock-in lines blocked
tolerance. I also noticed the repressing effect of HDAC was stronger when the HDAC
transgene was induced before a drug exposure that has been shown to induce histone
acetylation, suggesting that docking an HDAC at specific DNA elements (6b and 55b) of
slo control region represses drug-induced slo activation.
The HS-GAL4DBD-HAT; slo6bUAS stock developed tolerance to benzyl alcohol when
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the HAT transgene was not activated (Fig. 4.5A). Heat shock induction of HAT
expression had no effect on benzyl alcohol resistance or tolerance (Fig. 4.5B-D). The
same results were observed in HS-GAL4DBD-HAT; slo55bUAS animals (Fig. 4.6). Thus,
tethering a Gal4-HAT at either 6b or 55b had no effect on the capacity of flies to acquire
benzyl alcohol tolerance.
I also measured neural slo message abundance in the two-part system (Fig. 4.7).
Total RNA was prepared 6 h after the first drug exposure and quantitated by real-time
RT-PCR using C1 primers that specifically recognize neural transcript variants. Benzyl
alcohol did not increase slo message abundance in HS-GAL4DBD-HDAC; slo6bUAS when the
HDAC was activated by a heat shock treatment (Fig. 4.7A), however, the drug-induced
slo expression was detected in HS-GAL4DBD-HDAC; slo6bL control animals (Fig. 4.7B). In
contrast, activating the HAT increased slo abundance in both HS-GAL4DBD-HAT; slo6bUAS
and its control. Similar results were obtained in HS-GAL4DBD-HDAC; slo55bUAS and HS-
GAL4DBD-HAT; slo55UAS (Fig. 4.8).
To confirm that the ablation of tolerance by the Gal4-HDAC fusion protein was
due to the HDAC activity and was not merely a product of the physical binding of a
GAL4DBD to specific slo DNA elements I used the HS-GAL4DBD transgene. The derived
HS-GAL4DBD; slo55bUAS animals were subjected to a heat shock treatment to induce the
GAL4DBD that binds to the UAS motif adjacent to the 55b element. Twenty-four hours
later, the animals received the first benzyl alcohol sedation, followed by the tolerance
assay. The total RNA was prepared 6 h after the first drug exposure and quantitated by
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real time RT-PCR using C1 primers that recognize the neural transcript variants. I found
that both the HS-GAL4DBD; slo55bUAS stock and its control line acquired tolerance to benzyl
alcohol after the activation of the GAL4DBD, and the slo message in both lines was
induced (Fig. 4.9).
Discussion
The induction of the slo gene has been shown to be important for the development
of anesthetic drug tolerance13,46, Changes in histone H4 acetylation across the slo
transcription regulatory region have been correlated with benzyl alcohol induction of slo
expression and functional tolerance. Moreover, administration of a universal HDAC
inhibitor, sodium butyrate, leads to hyperacetylation at the 6b area of slo control region,
induces of slo expression and leads to a phenotype similar to tolerance68. This evidence
suggests that histone acetylation is involved in slo induction and the generation of
tolerance. However, it is not clear that histone acetylation within slo is necessary for the
acquisition of tolerance. To further evaluate the role of histone acetylation I used a two-
part system that ties histone modifiers adjacent to the conserved DNA elements 6b or 55b
of the slo gene. Tethering of an HDAC adjacent to either 6b or at 55b blocked tolerance.
However, the effect of the HDAC at 6b appeared to be stronger because animals not only
failed to acquire tolerance but also showed drug sensitization following a single benzyl
alcohol sensitization. This observation suggests that the 6b element is more important in
the production of benzyl alcohol tolerance. In concordance with this hypothesis are the
results using the 6b knockout allele (Chapter 2) and the 55b knockout allele (Chapter 3).
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Transcriptional regulation in eukaryotes is strongly influenced by the post-
translational modification of histones. Histone acetylation is the best understood
modifications that has been shown to correlate with gene activity: hyperacetylation with a
HAT usually causes an increase in gene expression, while an HDAC results in
hypoacetylation that is generally correlated with transcriptional inactivation,
heterochromatin and silenced genomic areas121,122.
It has been previously proposed that an HDAC is chronically positioned in the
vicinity of the 6b element. The basis for this supposition is that the administration of a
universal HDAC inhibitor causes hyperacetylation at the 6b region which also results in
the induction of slo68. This suggests that an HDAC at the 6b DNA element inhibits basal
expression of slo. In this model, after benzyl alcohol exposure, the HDAC dissociates
from the 6b element resulting in slo induction. I propose that the Gal4-HDAC artificially
positioned at the 6b element cannot be released after drug exposure, and that this blocks
slo induction and prevents tolerance.
The HDAC transgene used in this study is an Rpd3 allele that has been shown to
successfully modify chromatin in Drosophila follicle cells120. To date, six different
Drosophila HDACs have been identified. These are Rpd3, HDAC3, HDAC4, HDAC6-S,
HDAC6-L, and Sir2123. None of these HDACs exhibit any DNA binding activity, thus
corepressor proteins with DNA-binding domains are thought to be involved in forming
HDAC complexes to position the histone modifier to specific genes124. In their native
form, some HDACs, including Rpd3/HDAC1, are only active within a complex, and a
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complex may contain more than one HDAC125.
It is interesting that the tethering of the RPD3 HDAC domain (Gal4DBD-HDAC) at
either 6b or 55b does not affect basal expression of slo nor does it affect benzyl alcohol
sensitivity. Only after benzyl alcohol sedation is the effect of the tethered HDAC
observed.
There are two hypotheses that could account for this behavior. The first hypothesis
is that the effect the HDAC is only detectable when its substrate, acetylated histones,
increase in concentration. Perhaps, the affinity of the active site for its substrate (Km) is
insufficient to support deacetylation. After benzyl alcohol sedation, the acetylation level
climbs and raises the local substrate concentration to a level that permits enzyme activity.
A counter hypothesis is that the tethered HDAC is being actively regulated in
response to benzyl alcohol sedation. Perhaps, the activation of the Rpd3 HDAC domain
depends on its cofactor proteins and that these respond to benzyl alcohol sedation.
In this study, the heat-inducible GAL4DBD:HAT transgene had no effect on drug
resistance or tolerance. The HAT transgene in use is a chameau allele that has been
shown to enhance DNA replication origin activity in vivo120. The Drosophila Chameau
belongs to the MYST HAT family (named after its members MOZ, Ybf2/Sas3, Sas2, and
Tip60) and is homologous to the human HAT HBO1. MYST HATs have been shown to
activate gene transcription and DNA repair, but they are also involved in transcription
silencing126. Chameau has been shown to promote H4 acetylation at AP-1 target sites and
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activate AP-1 dependent transcription127. While modification of histone acetylation is
usually linked to transcriptional activation, recent evidence also suggests that Chameau
mediated histone acetylation is required for the maintenance of Hox gene repression128.
Like HDACs, most HATs exist as components of multisubunit complexes, and their
substrate preference and gene-specific localization are affected by the cofactors in the
same complex129. Lacking the essential co-activators for the Chameau HAT in this
preparation might have prevented the formation of a functional HAT complex.
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Figure 4.1. The scheme to tether chromatin modifiers to the 6b element in
slo control region. One copy of UAS, the Gal4 binding motif, was inserted
at the 5' of the 6b element to generate a slo6bUAS mutation. Then a Gal4
fusion transgene that contains a heat-inducible hsp70 promoter (red box)
driving expression of the GAL4 DNA binding domain (DBD) (blue box)
fused to HDAC (yellow box) was introduced to the slo6bUAS allele through
genetic crossing. Heat-induced expression in progeny with both alleles
results in binding of GAL4:HDAC to the UAS motif adjacent to the 6b
element. Similarly, other chromatin modifiers can be docked to the 6b
element by using specific Gal4 fusion transgene. This strategy is also
applicable to the modification of the 55b element.
















Figure 4.2. Southern analysis of knock-in alleles. A) Southern analysis of
slo6bUAS. Genomic DNA was digested with HindIII and detected using a
probe made of the 3'-homologous fragment. DNA from wild type shows a
5.6-kb fragment; homologous targeted alleles showing a 10.4-kb band; and
heterozygous targeted allele shows two bands. B) Southern blot analysis of
slo55bUAS. Genomic DNA was digested with HindIII and detected using a
probe made of the 3'-homologous fragment. DNA from wild type shows a
5.7-kb fragment; DNA from homologous targeted alleles show a 10.4-kb
































































Figure 4.3. Tethering HDAC at the 6b element blocked tolerance. A) HS-
GAL4DBD-HDAC; slo6bUAS and its control HS-GAL4DBD-HDAC; slo6bL
acquired tolerance to BA when HDAC was not activated. B) Docking
HDAC at 6b region did not affect drug resistance in both lines. C) Docking
HDAC at 6b region before drug treatment sensitized the fly to sedation. D)
Tethering HDAC at 6b after the first drug exposure blocked tolerance.
However, the heat shock treatment in both C and D did not affect tolerance
in the control line.












































































































































































Figure 4.4. Tethering HDAC at the 55b element blocked tolerance. A) HS-
GAL4DBD-HDAC; slo55bUAS and its control line HS-GAL4DBD-HDAC; slo55bL
acquired tolerance to BA when HDAC was not activated. B) Docking
HDAC at 55b region did not affect drug resistance. C) Docking HDAC at
55b region before drug treatment blocked tolerance. D) Tethering HDAC
at 55b after the first drug exposure blocked tolerance. However, the heat
shock treatment in both C and D did not affect tolerance in the control line.














































































































































































Figure 4.5. Tethering HAT at the 6b element had no effect on drug
resistance or tolerance. A) HS-GAL4DBD-HAT; slo6bUAS acquired tolerance to
BA when HAT was not activated. B) Tethering of Hat at 6b region did not
affect drug resistance. C) Docking of HAT at 6b region before the first
drug exposure no effect on tolerance. D) Tethering HAT at 6b after the
first drug exposure had no effect on tolerance.














































































































































































Figure 4.6. Tethering HAT at the 55b element had no effect on drug
resistance or tolerance. A) HS-GAL4DBD-HAT; slo55bUAS acquired tolerance
to BA when HAT was not activated. B) Tethering of Hat at 55b region did
not affect drug resistance. C) Docking of HAT at 55b region before the
first drug exposure no effect on tolerance. D) Tethering HAT at 55b after
the first drug exposure had no effect on tolerance.









































































































































































Figure 4.7. The slo message abundance in HS-GAL4DBD-HDAC; slo6bUAS.
Animals were subjected to heat shock at 37°C for 1 h to induce the histone
modifier transgene, and a benzyl alcohol sedation 24 h later. RNA was
prepared 6 h after sedation. A) Benzyl alcohol did not increase slo message
in HS-GAL4DBD-HDAC; slo6bUAS when HDAC was activated. B) Drug
induced slo message in GAL4DBD-HDAC; slo6bL control animals. C, D)
Docking of HAT at 55b region increase slo abundance in both HS-




































































































Figure 4.8. The slo message abundance in HS-GAL4DBD-HDAC; slo55bUAS.
Animals were subjected to heat shock at 37°C for 1 h to induce the histone
modifier transgene, and a benzyl alcohol sedation 24 h later. RNA was
prepared 6 h after sedation. A) Benzyl alcohol did not increase slo message
in HS-GAL4DBD-HDAC; slo55bUAS when HDAC was activated. B) Drug
induced slo message in GAL4DBD-HDAC; slo55bL control animals. C, D)
Docking of HAT at 55b region increase slo abundance in both HS-



































































































Figure 4.9. Tethering GAL4DBD at the 55b element alone had no effect on
tolerance. To investigate if GAL4DBD also blocked slo induction and
tolerance, HS-GAL4DBD; slo55bUAS animals were subjected to heat shock at
37°C for 1 h to induce GAL4DBD that binds to the UAS motif adjacent to
the 55b element. Twenty-three hours later, the animals received the first
benzyl alcohol sedation, followed by tolerance assay one day later. RNA
was prepared 6 h after the first drug exposure and quantitated by real time
PCR using C1 primers that recognize the neural transcript variants. A) The
HS-GAL4DBD; slo55bUAS stock and its control line acquired tolerance to
benzyl alcohol after activating GAL4DBD. B) The slo messages in both lines
were induced. C&D) slo message was significantly induced in both lines.
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Flies were raised on standard cornmeal food and kept at 22°C in a 12:12 hrs
light:dark cycle. Flies that emerged from pupae were collected over a 2-day period,
transferred to fresh food, and studied three days later. Drosophila stocks were wild type
CS, slo6bUAS, slo55bUAS, hsf4, Gal4DBD, Gal4DBD:HAT and Gal4DBD:HDAC. The last three
strains were from B. Calvi. hsf4 is a temperature-sensitive allele from the Bloomington
stock center (Bloomington IN). Adults homozygous for hsf4 develop normally at
permissive temperature (25°C and below) but not at 29°C or higher temperature130.
Generation of slo6bUAS and slo55bUAS knock-in mutants
To generate the slo6bUAS allele, a copy of the UAS sequence was inserted to the 5'
end of the 6b DNA element in slo regulatory region using ends-out gene targeting
strategy88. At first, the 5' homologous sequence containing a UAS next to the 6b element
and the 3' homologous sequence were amplified by PCR using Canton S genomic DNA
as the template and a proofreading PfuTurbo DNA polymerase (Stratagene CA). More
specifically, primers 5'-GCGGCCGCACCACAAGTTCCCCAAAAC-3' and 5'-
CGTATTTAAATTCTCAGTTCTCG-3' were used to amplify and add NotI and SwaI
termini to the 5' end and the 3' end, respectively, to a 1 kb fragment upstream of the 6b
element; primers 5'-TTTAAACGGAGTACTGTCCTCCGAACGGCGAGAATAGTGC
TGATTTTG-3' and 5'-TAGCTTTGTTTGCCCACGA-3' were used to amplify and add a
DraI and a UAS site to the 5' end of a 0.4 kb fragment with the 6b located at the 5' end;
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primers 5'-AATTAATTACCGCGTTCGTC-3' and 5'-ACTAGTGCATGCTCGCAAA
GCAAACACACTC-3' were used in the PCR to amplify and add the SphI and the SpeI
sites to the 3' end of a 2.3 kb DNA fragment downstream of the 6b element. These three
fragments were digested with corresponding restriction enzymes and ligated to form a 3.5
kb fragment before being inserted into the polylinker at 5' of white+ gene marker in the
ends-out vector pW2595, between the NotI site and the SphI site. While primers 5'-
GGCGCGCCATTACAAATTAACACCCAGTTGTG-3' and 5'-CCTAGGCGAATTC
GAAAAGCGTTAGC-3' were designed to amplify and add AscI terminal to the 5' end,
and add AvrII terminal to the 3' end of a 3 kb DNA fragment into the polylinker to the 3'
end of white+ gene in the vector. This donor construct was introduced into the white1118
fly by standard P element germline transformation. All the insertion lines were mapped
for the location of the donor transgene, and lines with the donor transgene on the first or
the second chromosome were utilized to induce gene targeting. The target gene slo is
located on the third chromosome.
To induce targeting, donor insertion lines are crossed to the
P{hsp70FLP}P{hsp70I-SceI} strain (Bloomington # 6934), and the progeny were heat-
shocked at 38°C for one hour during their first three days of development to induce
transgenic FLP and I-SceI that acted on their corresponding recognition sites in the ends-
out vector. The donor fragment, including two pieces of homologous fragments and a
white+ in between, was hopped out from its original insertion site in a circular form under
the action of FLP recombinase, and a double-strand break was introduced to linearize the
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donor by restriction enzyme I-sceI. These changes allow pairing and crossover between
the homologous fragments of donor and the targeted chromosomal 6b region. Thus that
6b was replaced by the white+ from the donor sequence. Virgin females with white+ and
P{hsp70FLP}P{hsp70I-SceI} are collected and crossed to male FLP flies (Bloomington #
6938), and the progeny are screened for solid red eyes. The white+ gene was mapped to
identify targeted events in which white+ was relocated to the target chromosome 3. And
Southern blotting was carried out to further confirm targeted events occurred exactly in
the designed position, and the targeted alleles were sequenced to confirm if they carry the
UAS motif. Finally, the targeted strain was crossed to P{Cre} line (Bloomington # 1501)
to remove the white+ maker and obtain the UAS knock-in mutant slo6bUAS. When the
homologous recombination took place downstream of the UAS sequence in the donor,
the control line slo6bL was obtained that contains all the chromosomal background as the
knock-in line, except for the UAS motif.
The slo55bUAS allele was generated using the same strategy except that a UAS motif
was inserted at the 5' end of the 55b DNA element. To build the donor construct, primers
5'-GCGGCCGCCAGGATACGCAGATACCCAGATAC-3' and 5'-GCATGCAATTGG
ATTGAATTTAGAAGT-3' were used to amplify and a NotI site to the 5' end and a SphI
site to the 3' end, respectively, of a 3.2 kb fragment upstream of the 55b element. The




were used to amplify and add an AscI site to the 5' end, and add a copy of UAS sequence
to the 3' end of a 1.2 kb fragment adjacent to the 5' end of the 55b element; primers 5'-
CCTGCCGTTGTCTCTTCTTC-3' and 5'-CTGCAGCCTAGGCGAATTCGAAAAGC
GTTAGC-3' were used to amplify and add an AvrII site to the 3' end of a 2 kb DNA
fragment with the 55b element at the 5' end. The two fragments were digested and ligated
to form a 3.2 kb fragment that was inserted into the polylinker to the 3' end of white+ in
the pW25 vector, between the AscI site and AvrII site.
The slo6bUAS and slo55bUAS lines were crossed to stocks expressing histone
acetylation modifiers (Gal4DBD-HDAC and Gal4DBD-HAT) to tether the histone
acetyaltion modifying protein to either the 6b element or the 55b element. The derived
double mutants were subjected to the benzyl alcohol exposure and tolerance assay.
Southern blotting analysis
Southern blot analyses were performed to verify the knock-in targeting events
using a DIG kit (Roche Diagnostics, IN) as recommended by the manufacturer. Genomic
DNA was prepared from flies carrying the targeted allele and wild type, followed by
overnight digestion with HindIII (NEB, MA), separated by agarose gel electrophoresis
and transferred to nylon membranes as described96. The probe DNA in use was the 3'
homologous fragment of donor construct. The blot was hybridized to the digoxigenin
(DIG) labeled probe and was detected by DIG antibody and chemiluminescence signal.
Benzyl alcohol exposure and tolerance assay
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The benzyl alcohol exposure and tolerance assay were conducted as described in
Chapter 2. To activate the heat-inducible Hdac/Hat transgene, the animals were subjected
to a 60 min heat shock at 37°C 24 h before the first drug exposure, and 48 h before the
tolerance assay. Alternatively, heat shock was conducted 24 h after the first drug
exposure, and 24 h before the tolerance assay.
Quantitative RT-PCR analysis
Animals were subjected to heat shock at 37°C for 1 h to induce the histone
modifier transgene (HDAC or HAT), and a benzyl alcohol sedation 24 h later. RNA was
prepared from fly body 6 h after the first sedation. The quantitive RT-PCR was
conducted as described in Chapter 2.
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Chapter 5: Conclusions and future directions
Summary and conclusions
Drug tolerance and withdrawal are insidious responses to drugs of abuse; the first
increases drug consumption while the second punishes abstention. These two
endophenotypes of addiction are thought have a common origin in the homeostatic
adaptations triggered to counter the drug effects. The very adaptations that cause drug
tolerance by reducing the response to the drug also generate symptoms of withdrawal
after drug clearance. Drosophila generate functional tolerance to benzyl alcohol sedation
by increasing neural expression of the slo BK channel gene. While this homeostatic
response counters the effects of the anesthetic, the persistence of the response after drug
clearance produces a withdrawal phenotype-an increase in the susceptibility to seizures53.
Benzyl alcohol induces histone acetylation across the slo control region, and
enhanced histone acetylation has been detected over two highly conserved DNA
regulatory elements–6b and 55b. To investigate the function of these two elements, I
generated individual knock-out mutants through Ends-Out gene targeting. Both of the
deletions affected the epigenetic profile and the animal's behavior. The 6b deletion
caused the animal to overreact to benzyl alcohol. It significantly enhanced drug-induced
slo expression but did not affect basal slo expression. The deletion of 6b prolonged the
duration of tolerance. In wild type flies tolerance only lasts about one week, however, the
6b deletion mutant showed a persistent tolerance that lasts at least a month. It also
increased the physiological response to drug sedation. The ablation of 55b element did
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not affect the ability to acquire tolerance, nor the effect of drug sedation on slo induction.
However, the 55b mutant did show increased basal muscle expression and an increase in
locomotor activity. Thus the 6b element has been identified as a drug-responsive negative
regulator of the slo neural expression and the 55b element has been identified as a
regulator of  basal slo muscle expression.
To manipulate the endogenous acetylation level over 6b and 55b elements, I built
another two mutants that have a UAS sequence next to each element. These UAS mutants
were crossed to a transgenic fly carrying a heat shock promoter driven GAL4DBD-HDAC
(GAL4 DNA binding domain linked histone deacetylase) or GAL4DBD-HAT (GAL4 DNA
binding domain linked histone acetylase). The derived double mutants were heat-shocked
to induce the expression of HDAC or HAT, and tested for the ability to acquire drug
tolerance. I found that activation of a HDAC transgene blocked slo induction and the
ability to acquire functional tolerance. Therefore, the local histone acetylation status
across slo promoter region plays an important role in the activation of slo and the
development of tolerance.
Future directions
To further explore how the 6b element regulates slo expression and drug responses.
In this study, the 6b DNA element is characterized as a repressive regulator of slo
expression after benzyl alcohol sedation. By controlling neural slo expression, it also
alters multiple drug responses, such as tolerance and withdrawal syndromes. The
mutation increased the magnitude of the neural slo induction after benzyl alcohol
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sedation, but the duration was not prolonged. The 6b deletion mutant also showed
extremely prolonged tolerance (28 days), while the behavioral changes in withdrawal
phenotypes did not show abnormally long persistence.
How can I reconcile the difference in the duration of slo expression, tolerance, and
the withdrawal phenotypes in the 6b mutant? It is possible that tolerance and the
withdrawal phenotypes arise from different structures in the brain. In this scenario, the
time-course of the slo∆6b expression in the neurons that produce tolerance would be longer
than in the neural structures that produce the withdrawal phenotype. If this is the case,
then one must also account for why long-lasting slo induction was not observed in slo∆6b.
This might occur if tolerance is produced by a small brain region whose persistent
induction cannot be detected in our whole brain mRNA assays. To resolve these issues,
future studies should focus on measuring brain specific levels of slo expression in the
nervous system after drug exposure. Unfortunately, Drosophila in situ hybridization does
not have either sufficient sensitivity or a signal-to-noise ratio that makes it useful for this
purpose. Furthermore, I do not have an appropriate Drosophila-specific BK channel
antibody to trace the dynamic change of slo expression in the nervous system after drug
sedation. A more modern solution to solve the lack of SLO-specific antibodies would be
to epitope-tag the BK channel gene (in the slod6b background) as a way to provide a
traceable slo protein.
To study the role of transcription factor HSF on tolerance.
A putative HSE, the binding site of transcription factor HSF (heat shock factor),
has been identified in the 6b DNA element68. HSF stays in an inactive state in unstressed
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cells and becomes activated in response to stress. HSF and the stress pathway protect
mammals and flies against the stressor and many other insults, such as ethanol
intoxication131,132. In flies, a brief heat pulse results in a reduction in slo expression13. I
hypothesize that the transcription factor HSF might play a role in drug-induced slo
activation and the development of tolerance (see Chapter 2, discussion).
To test this hypothesis, I used a temperature sensitive hsf4 allele to determine if
HSF is involved in producing tolerance. In the assay, female hsf4 and wild type flies were
kept at 18°C after eclosion. On day 3, flies were transferred to a 30°C incubator (with a
light-dark 12:12 cycle) for 30 min to inactivate the HSF transcription factor. This was
immediately followed by benzyl alcohol sedation or mock sedation. These animals were
allowed to recover from sedation at 30°C. Twenty-two hours (at 30°C) after the first
benzyl alcohol exposure, flies were incubated at 18°C for 30 min to reduce the net effect
of heat on the neural activity. One and a half hours later (24 hours post benzyl alcohol
exposure), flies were subjected to the tolerance assay at room temperature. In parallel, the
hsf4 and wild type flies that had been maintained at 18°C were also tested for the capacity
to acquire tolerance. The slo message abundance in these animals was also quantified.
As shown in Fig. 5.1 and Fig. 5.2, the homozygous hsf4 mutant acquired tolerance
at the permissive temperature (18°C), and the slo gene was induced after sedation. While
at the restrictive temperature (30°C), the hsf4 mutation blocked tolerance and benzyl
alcohol-induced slo induction. In contrast, the wild type CS flies were able to develop
tolerance and induce slo expression after sedation at either temperature (18°C and 30°C).
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These results suggest that HSF is required for the drug-induced slo activation and the
development of tolerance. Future studies should be directed to examine whether the HSF
transcription factor binds within the slo control region (especially the 6b element).
Identification of another transcription factor that helps to mediate slo-dependent drug
tolerance will greatly enrich our understanding of this drug response.
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Figure 5.1. The hsf4 mutation blocked rapid tolerance to benzyl alcohol sedation.
Hsf4 is a temperature sensitive mutant of the transcription factor HSF. At the
permissive temperature (18°C) both the mutant and CS wild type flies acquired
tolerance (A, B). At the restrictive temperature (30°C), the disruption of HSF
blocked tolerance in the mutant (C), while the CS animals still acquired tolerance
(D).
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Figure 5.2. The hsf4 mutation blocked benzyl alcohol induced slo
transcriptional activation. Benzyl alcohol induced slo transcription at 18°C
in both the ts mutant line (A) and the CS control line (B). At 30°C, slo
expression in the hsf4 mutant was not induced by the drug (C), while CS
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